Jump to contents

Researcher Information

last modified：2024/04/04

Professor　KINUYA Seigo

Mail Laboratory Website

Faculty, Affiliation

Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences
Professor
Vice President, University Hospital

College and School Educational Field

Division of Medical Sciences, Graduate School of Medical Science
Division of Medicine, Graduate School of Medical Science
School of Medicine, College of Medical, Pharmaceutical and Health Sciences

Laboratory

Department of Nuclear Medicine　TEL:076-265-2333　FAX:076-234-4257

Academic Background

【Academic background(Doctoral/Master's Degree)】
Kanazawa University　Doctor　Graduate School, Division of Medicine　Internal medicine, NUclear Medicine　199003　Completed
【Academic background(Bachelor's Degree)】
Kanazawa University　Medicine　198603
【Degree】
MD

Career

Kanazawa University　University Hospital　Vice President(2016/04/01-)
Kanazawa University　University Hospital　Director aide(2014/04/01-2016/03/31)
Kanazawa University　University Hospital　Vice President(2012/04/01-2014/03/31)
Kanazawa University　Institute of Medical. Pharmaceutical and Health Sciences, Department of Nuclear Medicine　Professor(2006/10/16-)
Kanazawa University　University Hospital, Department of Nuclear Medicine　Assisstant Professor(2006/04/01-2006/10/15)
School of Medicine, Kanazawa University　Department of Nuclear Medicine　Assisstant(1995/10/01-2006/03/31)
School of Medicine, Kanazawa University　Department of Nuclear Medicine　Staff doctor(1992/11/01-1995/09/30)
National Institutes of Health, USA　Clinical Center, Deapartment of Nuclear Medicine　Visiting fellow(1990/10/29-1992/10/31)
School of Medicine, Kanazawa University　Department of Nuclear Medicine　Staff doctor(1990/08/01-1990/10/28)
Hokuriku Central Hospital　Internal Medicine　Staff doctor(1990/04/01-1990/07/31)

Year & Month of Birth

Academic Society





Japanese Society of Nuclear Medicine
Japanese Society of Nuclear Medicine
Japanese Society of Nuclear Medicine


JASCC

Japanese Society of Nuclear Medicine
Society of Nuclear Medicine









Multinational Association of Supportive Care in Cancer
World Federation of Nuclear Medicine and Biology

Asia Oceania Federation of Nuclear Medicine and Biology
World Association of Radiopharmaceutical Therapy

Award

○Top Reviewer Certificate(2021/02/26)
○Top Reviewer Certificate(2019/12/18)
○Second Place Poster - Cardiovascular (2019/06/25)
○Magna Cum Laude (Europaen Association of Nuclear Medicine)(2000/09/01)
○Magna Cum Laude (Europaen Association of Nuclear Medicine)(2000/09/01)
○Magna Cum Laude (Europaen Association of Nuclear Medicine)(2000/09/01)
○Magna Cum Laude (Europaen Association of Nuclear Medicine)(2000/09/01)
○Best Science Paper in European Journal of Nuclear Medicine(2002/09/04)
○Best Science Paper in European Journal of Nuclear Medicine(2002/09/04)

Specialities

Nuclear Medicine、、Biomolecular chemistry

Speciality Keywords

Nuclear Medicine, radionuclide therapy

Research Themes

Tumor detection and treatment with radiopharmaceuticals

Books

  • 　Combined radioimmunotherapy with antiangiogenic therapy to treat cancer: validation studies in animal models　Nova Science Publishers, Inc.
  • 　Assessment of cancer drug resistance with nuclear medicine images　Nova Science Publishers, Inc
  • 　Li X-F, Bai J, Yokoyama K, Michigishi T, Tonami N　Prediction of therapeutic responses to chemotherapy and monitor of effects of MDR-modulation with radiotracers in malignant tumors　Nova Science Publishers, Inc　2006/11
  • 　若林大志、稲木杏吏、萱野大樹、絹谷セイゴ　内分泌腫瘍（第2版）　2020/09/30

Papers

  • 　Manual on the proper use of the 211At‑labeled PSMA ligand ([211At]PSMA‑5) for clinical trials of targeted alpha therapy (1st edition)　Watabe T, Namba M, Yanagida S, Nakamura Y, Yamada T, Tatsuno S, Ri A, Yoshida S, Uyama K, Kinuya S, Tomiyama N, Hosono M.　Ann Nucl Med　2024/03/28
  • 　Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor　Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami, Kohshin Washiyama, Kenji Mishiro, Hiroshi Wakabayasi, Kazuhiro Takahashi, Seigo Kinuya, Kazuma Ogawa　Eur J Nucl Med Mol Imaging　2024/03/21
  • 　Synthesis and evaluation of radiogallium labeled bone imaging probes using oligo-γ-carboxy glutamic acid peptides as carriers to bone　Kazuma Ogawa, Kota Nishizawa, Kenji Mishiro, Nurmaya Effendi, Takeshi Fuchigami, Masayuki Munekane, Hiroshi Wakabayashi, Seigo Kinuya　Molecular Pharmaceutics　2024/03/20
  • 　Flare phenomenon visualized by 99mTc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer　Xue Zhang, Kenichi Nakajima, Atsushi Mizokami, Hiroyuki Horikoshi, Koshiro Nishimoto, Katsuyoshi Hashine, Hideyasu Matsuyama, Satoru Takahashi, Hiroshi Wakabayashi, Seigo Kinuya 　Ann Nucl Med　2024/03/13
  • 　Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia.　Nakajima K, Shibutani T, Massanes F, Shimizu T, Yoshida S, Onoguchi M, Kinuya S, Vija AH.　J Nucl Cardiol　2023/09/27

show all

  • 　Transthyretin amyloid cardiomyopathy disease burden quantified using 99mTc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours　Satoru Watanabe, Kenichi Nakajima, Fumihito Toshima, Hiroshi Wakabayashi, Shohei Yoshida, Hiroto Yoneyama, Junji Komatsu, Takahiro Konishi, Seigo Kinuya　J Nucl Cardiol　2023/08/22
  • 　125I-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (125I-OI5V) imaging visualized augmented sigma-1 receptor expression according to the severity of myocardial ischemia.　Wakabayashi H, Mori H, Hiromasa T, Akatani N, Inaki A, Kozaka T, Kitamura Y, Ogawa K, Kinuya S, Taki J.　J Nucl Cardiol　30　2　653-661　2023/08/01
  • 　Development of probes for radiotheranostics with albumin binding moiety to increase the therapeutic effects of astatine-211 (211At).　Echigo H, Mishiro K, Munekane M, Fuchigami T, Washiyama K, Takahashi K, Kitamura Y, Wakabayashi H, Kinuya S, Ogawa K.　Eur J Nucl Med Mol Imaging　2023/10/11
  • 　Influence of spill-over for 99mTc images and the effect of scatter correction for dual-isotope simultaneous acquisition with 99mTc and 18F using small-animal SPECT-PET/CT system.　Shibutani T, Onoguchi M, Kanno T, Kinuya S.　Phys Eng Sci Med　2023/10/30
  • 　Astatine-211-labeled aza-vesamicol derivatives as sigma receptor ligands for targeted alpha therapy　Kazuma Ogawa, Kota Nishizawa, Kohshin Washiyama, Masayuki Munekane , Takeshi Fuchigami, Hiroaki Echigo, Kenji Mishiro, Saki Hirata, Hiroshi Wakabayashi, Kazuhiro Takahashi, Seigo Kinuya　Nuclear Medicine and Biology　122-123　2023/07/28
  • 　Three-Dimensional Heart Segmentation and Absolute Quantitation of Cardiac 123I-metaiodobenzylguanidine Sympathetic Imaging Using SPECT/CT　Saito S, Nakajima K, Shibutani T, Wakabayashi H, Yoneyama H, Konishi T, Mori H, Takata A, Kinuya S.　Ann Nucl Cardiol. 2023;9(1):61-67　9　1　61-67　2023/10/31
  • 　Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia　Kenichi Nakajima , Takayuki Shibutani , Francesc Massanes, Takeshi Shimizu, Shohei Yoshida, Masahisa Onoguchi, Seigo Kinuya & A. Hans Vija 　J Nucl Cardiol 　30　2773-2789　2023/09/27
  • 　Radiation exposure lymphocyte damage assessed by γ-H2AX level using flow cytometry　Chen Z, Wakabayashi H, Kuroda R, Mori H, Hiromasa T, Kayano D, Kinuya S　Sci Rep　14　1　4339　2024/02/22
  • 　Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine　Urbain JL, Scott AM, Lee ST, Buscombe J, Weston C, Hatazawa J, Kinuya S, Singh B, Haidar M, Ross A, Lamoureux F, Kunikowska J, Wadsak W, Dierckx R, Paez D, Giammarile F, Lee KH, O JH, Moshe M, Louw L, More S, Nadel H, Lee D, Wahl R.　J Nucl Med 　64　6　986-91　2023/05/04
  • 　Comparison of muscle activity, strength, and balance, before and after a 6-month training using the FIFA11+ program (part 2).　Oshima T, Nakase J, Inaki A, Mochizuki T, Takata Y, Shimozaki K, Kinuya S, Tsuchiya H.　J Orthop Surg (Hong Kong)　28　1　2309499019891541　2020/01
  • 　Calibrated scintigraphic imaging procedures improve quantitative assessment of the cardiac sympathetic nerve activity　Koichi Okuda, Kenichi Nakajima, Chiemi Kitamura, Yumiko Kirihara, Mitsumasa Hashimoto & Seigo Kinuya 　Scientific Report　10　21834 　2020/12/14
  • 　Thallium-201 Imaging in Intact Olfactory Sensory Neurons with Reduced Pre-Synaptic Inhibition In Vivo.　Shiga H, Wakabayashi H, Washiyama K, Noguchi T, Hiromasa T, Miyazono S, Kumai M, Ogawa K, Taki J, Kinuya S, Miwa T.　Mol Neurobiol　2020/08/20
  • 　A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma.　Wakabayashi H, Inaki A, Yoshimura K, Murayama T, Imai Y, Higuchi T, Jinguji M, Shiga T, Kinuya S　Sci Rep.　1　9　7625　2019/05/01
  • 　Introduction of the targeted alpha therapy (with Radium-223) into clinical practice in Japan: learnings and implementation　Hosono M, Ikebuchi H, Nakamura Y, Yanagida S, Kinuya S　Ann Nucl Med　2019
  • 　Design, synthesis, and biological evaluation of radioiodinated benzo[d]imidazolequinoline derivatives for platelet-derived growth factor receptor β (PDGFRβ) imaging　nurmaya effendi, Kenji Mishrio, Takeshi Takarada, Daisuke Yamada, Ryuichi Nishii, Kazuhiro Shiba, Seigo Kinuya, Akira ODANI, Kazuma Ogawa　Bioorganic & Medicinal Chemistry　2019
  • 　Development of Radiogallium-Labeled Peptides forPlatelet-Derived Growth Factor Receptorβ(PDGFRβ) Imaging:Influence of Different Linkers　Nurmaya Effendi , Kenji Mishiro , Kazuhiro Shiba, Seigo Kinuya and Kazuma Ogawa　Molecules　26　41　2020/12/23
  • 　The utility of heart-to-mediastinum ratio using a planar image created from IQ-SPECT with iodine-123 meta-iodobenzylguanidine　Shibutani T, Nakajima K, Yoneyama H, Konishi T, Okuda K, Onoguchi M, Kinuya S　J Nucl Cardiol　2020/02/10
  • 　Utility of bone SPECT/CT to identify the primary cause of pain in elderly patients with degenerative lumbar spine disease.　Kato S, Demura S, Matsubara H, Inaki A, Shinmura K, Yokogawa N, Murakami H, Kinuya S, Tsuchiya H.　J Orthop Surg Res　14　1　185　2019/06/20
  • 　Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017.　Nishiyama Y, Kinuya S, Kato T, Kayano D, Sato S, Tashiro M, Tatsumi M, Hashimoto T, Baba S, Hirata K, Yoshimura M, Yoneyama H　Ann Nucl Med　2019/06/24
  • 　A Report on Health Resource Use in Internal Radiation Therapy with Radium Chloride (223Ra) (2nd Survey)　Seigo KINUYA,Katsuhiko KATO,Takeshi KAMIOKA,Toshiyuki SHIMMURA,Yoshinori MATOBA,Kengo ITO,　KAKUIGAKU　54　1　603-621　2017
  • 　甲状腺癌の放射性ヨウ素内用療法におけるRI 治療病室稼働状況の実態調査報告（第4 報）　54　1　579–586　2017
  • 　Utility of 123I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma.　Wakabayashi H, Konishi T, Yoneyama H, Inaki A, Hiromasa T, Yamase T, Akatani N, Watanabe S, Mori H, Kayano D, Kinuya S.　Asia Ocean J Nucl Med Biol.　7　2　115-120　2019
  • 　Radiation exposure in nurses during care of 131I-MIBG therapy for pediatric patients with high-risk neuroblastoma.　Taniguchi Y, Wakabayashi H, Inaki A, Kayano D, Yamada M, Kinuya S.　2020/04/15
  • 　Syntheses and evaluation of a homologous series of aza-vesamicol as improved radioiodine-labeled probes for sigma-1 receptor imaging.　Ogawa K, Masuda R, Mishiro K, Wang M, Kozaka T, Shiba K, Kinuya S, Odani A.　Bioorg Med Chem.　10　27　1990-1996　2019/05/15
  • 　Imaging modalities for drug-related osteonecrosis of the jaw (5), utility of bone scintigraphy and 18F-FDG PET/CT in early detection and risk assessment of medication-related osteonecrosis of the jaw (secondary publication).　Watanabe S, Nakajima K, Kinuya S.　Jpn Dent Sci Rev　1　55　76-79　2019
  • 　A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma: a study protocol.　Inaki A, Yoshimura K, Murayama T, Imai Y, Kuribayashi Y, Higuchi T, Jinguji M, Shiga T, Kinuya S.　J Med Invest　64　3,4　205-209.　2017
  • 　Influence of Attenuation Correction by Brain Perfusion SPECT/CT Using a Simulated Abnormal Bone Structure: Comparison Between Chang and CT Methods.　Shibutani T, Onoguchi M, Miyamoto N, Yamamoto Y, Kinuya S.　J Nucl Med Technol.　45　3　208-213　2017
  • 　Design, synthesis, and biological evaluation of radioiodinated benzo[d]imidazole-quinoline derivatives for platelet-derived growth factor receptor β (PDGFRβ) imaging.　Effendi N, Mishiro K, Takarada T, Yamada D, Nishii R, Shiba K, Kinuya S, Odani A, Ogawa K.　Bioorg Med Chem.　2　27　383-393　2019/01
  • 　targeted radionuclide therapy with 131I-MIBG　Current therapy　37　2　49-55　2019/02/01
  • 　Front line of thyroid tumor treatment Current trend of the treatment Radioactive iodine therapy　Kinuya S　91　6　566-571　2019/06
  • 　Reliability of the muscle strength measurement and effects of the strengthening by an innovative exercise device for the abdominal trunk muscles.　Kato S, Inaki A, Murakami H, Kurokawa Y, Mochizuki T, Demura S, Yoshioka K, Yokogawa N, Yonezawa N, Shimizu T, Kinuya S, Tsuchiya H.　J Back Musculoskelet Rehabil. 　2019/10/15
  • 　current status of radioactive iodine therapy for thyroid cancer　89　10　900-908　2017
  • 　Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials.　Hosono M, Ikebuchi H, Kinuya S, Yanagida S, Nakamura Y, Yamada T, Sakaguchi K, Sugano H, Kojima K, Hatazawa J.　Ann Nucl Med.　33　11　787-805　2019/11
  • 　A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study.　Matsubara N, Kimura G, Uemura H, Uemura H, Nakamura M, Nagamori S, Mizokami A, Kikukawa H, Hosono M, Kinuya S, Krissel H, Siegel J, Kakehi Y.　Int J Clin Oncol. 　2019/12/10
  • 　Introduction of the targeted alpha therapy (with Radium-223) into clinical practice in Japan: learnings and implementation.　Hosono M, Ikebuchi H, Nakamura Y, Yanagida S, Kinuya S.　Ann Nucl Med　3　33　211-221　2019/03
  • 　Accuracy of an artificial neural network for detecting a regional abnormality in myocardial perfusion SPECT.　Shibutani T, Nakajima K, Wakabayashi H, Mori H, Matsuo S, Yoneyama H, Konishi T, Okuda K, Onoguchi M, Kinuya S.　Ann Nucl Med　2　33　86-92　2019/02
  • 　Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.　Uemura H, Uemura H, Nagamori S, Wakumoto Y, Kimura G, Kikukawa H, Yokomizo A, Mizokami A, Kosaka T, Masumori N, Kawasaki Y, Yonese J, Nasu Y, Fukasawa S, Sugiyama T, Kinuya S, Hosono M, Yamaguchi I, Akagawa T, Matsubara N.　Int J Clin Oncol　24　5　557-566　2019
  • 　Characteristics of single- and dual-photopeak energy window acquisitions with thallium-201 IQ-SPECT/CT system.　Shibutani T, Onoguchi M, Yoneyama H, Konishi T, Matsuo S, Nakajima K, Kinuya S.　Ann Nucl Med　31　7　529-535　2017
  • 　IQ-SPECT for thallium-201 myocardial perfusion imaging: effect of normal databases on quantification.　Konishi T, Nakajima K, Okuda K, Yoneyama H, Matsuo S, Shibutani T, Onoguchi M, Kinuya S.　Ann Nucl Med　31　6　454-461　2017
  • 　Targeted alpha therapy with 223Ra for castration-resistant bone metastases of prostate cancer　33　4　431-441　2017
  • 　去勢抵抗性前立腺がん骨転移に対する223Raα線内用療法　Clinical Imagiology　33　4　431-441　2017/04
  • 　Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases　Uemura H, Uemura H, Matsubara N, Kinuya S, Hosono M, Yajima Y, Doi T　Int J Clin Oncol　2017/05/06
  • 　Simultaneous acquisition of (99m)Tc- and (123)I-labeled radiotracers using a preclinical SPECT scanner with CZT detectors.　Simultaneous acquisition of (99m)Tc- and (123)I-labeled radiotracers using a preclinical SPECT scanner with CZT detectors.　Ann Nucl Med　30　4　263-271　2016
  • 　Correlation between apoptosis and left ventricular remodeling in subacute phase of myocardial ischemia and reperfusion.　Wakabayashi H, Taki J, Inaki A, Shiba K, Matsunari I, Kinuya S.　EJNMMI Res　5　1　72　2015
  • 　Synthesis and evaluation of a new vesamicol analog o-[(11)C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter.　Kitamura Y, Kozaka T, Miwa D, Uno I, Azim MA, Ogawa K, Taki J, Kinuya S, Shiba K.　Ann Nucl Med　30　2　122-129　2016
  • 　Methods of calculating 123I‑β‑methyl‑P‑iodophenyl‑pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy　Zhuoqing Chen, Kenichi Nakajima, Ken-ichi Hirano, Takashi Kamiya, Shohei Yoshida, Shintaro Saito, Seigo Kinuya 　Ann Nucl Med　36　11　986–997　2022/09/25
  • 　Exploratory Analysis Results from Post-marketing Surveillance Study of Radium-223 in Japanese Patients with Castration-resistant Prostate Cancer and Bone Metastases: Subgroup Analysis by Age　Hosono M, Uemura H, Kakehi Y, Masumori N, Takahashi S, Okayama Y, Sunaya T, Horio T, Kinuya S.　Kaku Igaku　58　1　91-101　2021/10/01
  • 　Convolutional neural network-based automatic heart segmentation and quantitation in 123 I-metaiodobenzylguanidine SPECT imaging　Saito S, Nakajima K, Edenbrandt L, Enqvist O, Ulén J, Kinuya S.　EJNMMI Res　11　1　105　2021/10/12
  • 　Manual on the proper use of sodium astatide ([211At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition).　 Watabe T, Hosono M, Kinuya S, Yamada T, Yanagida S, Namba M, Nakamura Y.　Ann Nucl Med　35　7　753-766　2021/07/01
  • 　A Radiobrominated Tyrosine Kinase Inhibitor for EGFR with L858R/T790M Mutations in Lung Carcinoma.　Fawwaz M, Mishiro K, Nishii R, Makino A, Kiyono Y, Shiba K, Kinuya S, Ogawa K.　Pharmaceuticals (Basel)　14　3　256　2021/03/12
  • 　Comparison of the detecting capability between 123I-mIBG and post-therapeutic 131I-mIBG scintigraphy for curie scoring in patients with neuroblastoma after chemotherapy.　Qiu ZL, Saito S, Kayano D, Wakabayashi H, Kinuya S.　Ann Nucl Med　35　6　649-661　2021/07/01
  • 　Prognostic factors for refractory pheochromocytoma and paraganglioma after 131I-metaiodobenzylguanidine therapy 　Hiromasa T, Wakabayashi H, Kayano D, Inaki A, Watanabe S, Mori H, Akatani N, Yamase T, Kunita Y, Saito S, Kinuya S.　Ann Nucle Med　2021/10/13
  • 　Skeletal muscle metabolism on whole-body positron emission tomography during pitching　Takata Y, Nakase J, Inaki A, Mochizuki T, Shimozaki K, Asai K, Kinuya S, Tsuchiya H.　J Int Soc Sports Nutr　18　1　21　2021/03/01
  • 　Clinical practice guidelines for high-resolution breast PET, 2019 edition. 　Satoh Y, Kawamoto M, Kubota K, Murakami K, Hosono M, Senda M, Sasaki M, Momose T, Ito K, Okamura T, Oda K, Kuge Y, Sakurai M, Tateishi U, Fujibayashi Y, Magata Y, Yoshida T, Waki A, Kato K, Hashimoto T, Uchiyama M, Kinuya S, Higashi T, Magata Y, Machitori A, Maruno H, Minamimoto R, Yoshinaga K.　Ann Nucl Med　35　3　406-414　2021/03/01
  • 　Metal artifact reduction for improving quantitative SPECT/CT imaging. 　Konishi T, Shibutani T, Okuda K, Yoneyama H, Moribe R, Onoguchi M, Nakajima K, Kinuya S　Ann Nucl Med　35　3　291-298　2021/01/18
  • 　In vitro and in vivo evaluation of [ 125/123 I]-2-[4-(2-iodophenyl)piperidino]cyclopentanol([ 125/123 I]-OI5V) as a potential sigma-1 receptor ligand for SPECT 　Ann Nucl Med　35　2　167-175　2021/01/08
  • 　Colchicine treatment early after infarction attenuates myocardial inflammatory response demonstrated by 14C-methionine imaging and subsequent ventricular remodeling by quantitative gated SPECT　Mori H, Taki J, Wakabayashi H, Hiromasa T, Inaki A, Ogawa K, Shiba K, Kinuya S.　Ann Nucl Med　35　2　253-259　2021/01/03
  • 　Visualization of Dynamic Expression of Myocardial Sigma-1 Receptor After Myocardial Ischemia and Reperfusion Using Radioiodine-Labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (OI5V) Imaging　Hiroshi Wakabayashi, Junichi Taki, Hiroshi Mori, Tomo Hiromasa, Norihito Akatani, Anri Inaki, Takashi Kozaka, Kazuhiro Shiba, Kazuma Ogawa, Seigo Kinuya　Circulation Journal　2021/06/26
  • 　Medical Innovation Course - achievements in 5 years and future perspective　Seigo Kinuya　34　5　326-329　2018
  • 　Precision medicine and nuclear medicine therapy　Kinuya S　32　1　26-29　2019/01/30
  • 　Peptide receptor radionuclide therapy (PRRT) for pancreatic neuroendocrine tumor　Seigo Kinuya　38　12　1413-1418　2017
  • 　Radiotherapy for neuroendocrine tumors - including PRRT　Seigo Kinuya　13　4　309-312　2017
  • 　Serial examination of cardiac function and perfusion in growing rats using SPECT/CT for small animals.　Hiromasa T, Taki J, Wakabayashi H, Inaki A, Okuda K, Shibutani T, Shiba K, Kinuya S.　Sci Rep　10　1　160　2020
  • 　Radiation Emission Rate of PET Acquisition in Routine Whole-Body 18F-FDG PET-CT Procedures　Ca˜nizares HG, Wakabayashi H, Takeda S, Mochizuki T and Kinuya S　AIP Conference Proceedings　2295　020017 　2020/12/01
  • 　Fully automated analysis for bone scintigraphy with artificial neural network: usefulness of bone scan index (BSI) in breast cancer.　Inaki A, Nakajima K, Wakabayashi H, Mochizuki T, Kinuya S　Ann Nucl Med　2019/07/17
  • 　Decreasing undesirable absorbed radiation to the intestine after administration of radium-223 dichloride for treatment of bone metastases.　Ogawa K, Higashi T, Mishiro K, Wakabayashi H, Shiba K, Odani A, Kinuya S.　Sci Rep. 　10　1　11917　2020/07/17
  • 　(-)-o-[11C]methyl-trans-decalinvesamicol ((-)-[11C]OMDV) as a PET ligand for the vesicular acetylcholine transporter　Synapse　2020/06/03
  • 　Prognostic Value of Early Evaluation of Left Ventricular Dyssynchrony After Myocardial Infarction. 　 Wakabayashi H, Taki J, Inaki A, Hiromasa T, Yamase T, Akatani N, Okuda K, Shibutani T, Shiba K, Kinuya S.　Mol Imaging Biol.　2019
  • 　Nasal thallium-201 uptake in patients with parosmia with and without hyposmia after upper respiratory tract infection　Hideaki Shiga, Koichi Okuda, Junichi Taki, Naoto Watanabe, Hisao Tonami, Seigo Kinuya, Takaki Miwa　International Journal of Allerrgy & Rhinology　2019/07/04
  • 　Assessment of neoadjuvant chemotherapy by scintigraphic images　J Jpn Orthop Assoc　92　953-958　2018
  • 　Synthesis and Evaluation of a Dimeric RGD Peptide as a Preliminary Study for Radiotheranostics with Radiohalogens 　iroaki Echigo, Kenji Mishiro, Takeshi Fuchigami, Kazuhiro Shiba, Seigo Kinuya and Kazuma Ogawa　Molecules　26　6107　2021/10/11
  • 　Accuracy of an artificial neural network for detecting a regional abnormality in myocardial perfusion SPECT. 　 Shibutani T, Nakajima K, Wakabayashi H, Mori H, Matsuo S, Yoneyama H, Konishi T, Okuda K, Onoguchi M, Kinuya S.　Ann Nucl Med　2019
  • 　Synthesis and evaluation of a multifunctional probe with a high affinity for prostate-specific membrane antigen (PSMA) and bone.　Hirata S, Mishiro K, Higashi T, Fuchigami T, Munekane M, Arano Y, Kinuya S, Ogawa K.　Nucl Med Biol　114-115　34-41　2022/08/24
  • 　Development of a novel small-animal myocardial phantom can evaluate the image quality of dual-isotope simultaneous acquisition (DISA)　Shibutani T, Onoguchi M, Kanno T, Wakabayashi H, Hiromasa T, Kinuya S.　Ann Nucl Med　36　12　1031-1038　2022/10/13
  • 　Development of tumor-targeting aza-vesamicol derivatives with high affinity for sigma receptors for cancer theranostics　Mishiro K, Wang M, Hirata S, Fuchigami T, Shiba K, Kinuya S, Ogawa K.　RSC Med Chem　13　8　986-997　2022/06/30
  • 　Current Trends and Issues in Therapeutic Nuclear Medicine and Proposed Solutions 　Inaki A, Kinuya S.　Gan To Kagaku Ryoho　49　8　853-859　2022/08/01
  • 　125I-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (125I-OI5V) imaging visualized augmented sigma-1 receptor expression according to the severity of myocardial ischemia.　Wakabayashi H, Mori H, Hiromasa T, Akatani N, Inaki A, Kozaka T, Kitamura Y, Ogawa K, Kinuya S, Taki J.　J Nucl Cardiol　2022/08/01
  • 　Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors. 　Kobayashi N, Takano S, Ito K, Sugiura M, Ogawa M, Takeda Y, Okubo N, Suzuki A, Tokuhisa M, Kaneta T, Utsunomiya D, Hata M, Inoue T, Hosono M, Kinuya S, Ichikawa Y.　Ann Nucl Med　2021/09/17
  • 　治療用放射性医薬品 131I-MIBG を投与された患者の退出に係る放射線防護上の検討　稲木 杏吏, 若林 大志, 萱野 大樹, 絹谷 清剛　58　1　59-66　2021/07/12
  • 　Synthesis and evaluation of radiogallium-labeled long-chain fatty acid derivatives as myocardial metabolic imaging agents　Nurmaya Effendi, Kenji Mishiro, Hiroshi Wakabayashi, Malwina Gabryel-Skrodzka, Kazuhiro Shiba, Junichi Taki, Renata Jastrząb, Seigo Kinuya, Kazuma Ogawa　Pros One　16　12　e0261226　2021/12/15
  • 　Synthesis and Evaluation of a Dimeric RGD Peptide as a Preliminary Study for Radiotheranostics with Radiohalogens. 　Echigo H, Mishiro K, Fuchigami T, Shiba K, Kinuya S, Ogawa K　Molecules　26　20　6107　2021/10/10
  • 　Feasibility of 125I-RGD uptake as a marker of angiogenesis after myocardial infarction.　 Yamase T, Taki J, Wakabayashi H, Inaki A, Hiromasa T, Mori H, Akatani N, Ogawa K, Shiba K, Kinuya S. 　Ann Nucl Med　2021/11/26
  • 　Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation.　Kuroda R, Wakabayashi H, Araki R, Inaki A, Nishimura R, Ikawa Y, Yoshimura K, Murayama T, Imai Y, Funasaka T, Wada T, Kinuya S.　Eur J Nucl Med Mol Imaging　2021/11/27
  • 　An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma.　Inaki A, Shiga T, Tsushima Y, Jinguji M, Wakabayashi H, Kayano D, Akatani N, Yamase T, Kunita Y, Watanabe S, Hiromasa T, Mori H, Hirata K, Watanabe S, Higuchi T, Tomonaga H, Kinuya S.　Ann Nucl Med　2021/12/06
  • 　Volumetric evaluation of 99mTc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters.　Watanabe S, Nakajima K, Wakabayashi H, Yoneyama H, Yoshida S, Komatsu J, Konishi T, Inaki A, Kinuya S.　J Nucl Cardiol　2021/12/14
  • 　Safety and response after peptide receptor radionuclide therapy with 177 Lu-DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trial. 　Kudo A, Tateishi U, Yoshimura R, Tsuchiya J, Yokoyama K, Takano S, Kobayashi N, Utsunomiya D, Hata M, Ichikawa Y, Tanabe M, Hosono M, Kinuya S.　J Hepatobiliary Pancreat Sci　2021/12/14
  • 　Synthesis and evaluation of radiogallium-labeled long-chain fatty acid derivatives as myocardial metabolic imaging agents. 　Effendi N, Mishiro K, Wakabayashi H, Gabryel-Skrodzka M, Shiba K, Taki J, Jastrząb R, Kinuya S, Ogawa K.　PLoS One　16　12　e0261226　2021/12/15
  • 　Application of a tungsten apron for occupational radiation exposure in nursing care of children with neuroblastoma during 131I-meta-iodo-benzyl-guanidine therapy. 　Taniguchi Y, Wakabayashi H, Yoneyama H, Chen Z, Morino K, Otosaki A, Yamada M, Inaki A, Kayano D, Kinuya S.　Sci Rep　12　1　47　2022/01/07
  • 　Development of Radiohalogenated Osimertinib Derivatives as Imaging Probes for Companion Diagnostics of Osimertinib. 　Mishiro K, Nishii R, Sawazaki I, Sofuku T, Fuchigami T, Sudo H, Effendi N, Makino A, Kiyono Y, Shiba K, Taki J, Kinuya S, Ogawa K.　J Med Chem.　2022/01/11
  • 　Evaluation of skeletal muscle activity during foot training exercises using positron emission tomography　Kanayama T, Nakase J, Mochizuki T, Asai K, Yoshimizu R, Kimura M, Kinuya S, Tsuchiya H.　Sci Rep. 　12　1　7076　2022/04/30
  • 　Manual on the proper use of meta-[ 211 At] astato-benzylguanidine ([ 211 At] MABG) injections in clinical trials for targeted alpha therapy (1st edition)　Ukon N, Higashi T, Hosono M, Kinuya S, Yamada T, Yanagida S, Namba M, Nakamura Y.　Ann Nucl Med　36　8　695-709　2022/07/06
  • 　Diagnosis of Parkinson syndrome and Lewy-body disease using 123 I-ioflupane images and a model with image features based on machine learning　Nakajima K, Saito S, Chen Z, Komatsu J, Maruyama K, Shirasaki N, Watanabe S, Inaki A, Ono K, Kinuya S.　Ann Nucl Med　2022/07/07
  • 　I-131 metaiodobenzylguanidine therapy is a significant treatment option for pheochromocytoma and paraganglioma　Zhang X, Wakabayashi H, Kayano D, Inaki A, Kinuya S.　Nuklearmedizin　61　3　231-239　2022/06
  • 　Prediction of multivessel coronary artery disease and candidates for stress-only imaging using multivariable models with myocardial perfusion imaging　Kunita Y, Nakajima K, Nakata T, Kudo T, Kinuya S.　Ann Nucl Med　36　7　674-683　2022/07
  • 　Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan.　Akatani N, Wakabayashi H, Kayano D, Inaki A, Takata A, Hiromasa T, Yamase T, Kunita Y, Watanabe S, Mori H, Saito S, Nakajima K, Kinuya S.　Endocr J　70　3　315-322　2023
  • 　An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma　Inaki A, Shiga T, Tsushima Y, Jinguji M, Wakabayashi H, Kayano D, Akatani N, Yamase T, Kunita Y, Watanabe S, Hiromasa T, Mori H, Hirata K, Watanabe S, Higuchi T, Tomonaga H, Kinuya S.　Ann Nucl Med　36　3　267-278　2022/03/01
  • 　Comparison of diagnostic performance of four software packages for phase dyssynchrony analysis in gated myocardial perfusion SPECT.　Okuda K, Nakajima K, Matsuo S, Kashiwaya S, Yoneyama H, Shibutani T, Onoguchi M, Hashimoto M, Kinuya S.　EJNMMI Res　2017
  • 　Fundamental study of radiogallium-labeled aspartic acid peptides introducing octreotate derivatives.　Ishizaki A, Mishiro K, Shiba K, Hanaoka H, Kinuya S, Odani A, Ogawa K.　Ann Nucl Med　2019/03/01
  • 　A case of frequent hypoglycemic attacks successfully controlled with capecitabine plus temozolomide and 177Lu-DOTATATE peptide receptor radionuclide therapy in a patient with recurrent pancreatic insulinoma　Takeshi Terashima, Tatsuya Yamashita, Naoki Takemura, Anri Inaki, Akinori Shimizu, Kenichi Harada, Taro Yamashita, Seigo Kinuya, Keiji Hanada　Clin J Gastroentherology　2023/06/20
  • 　Synthesis and evaluation of a deltic guanidinium analogue of a cyclic RGD peptide. 　Mishiro K, Ueno T, Wakabayashi H, Fukui M, Kinuya S, Ogawa K.　Org Biomol Chem　2023/02/08
  • 　Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma　Zhang X, Wakabayashi H, Hiromasa T, Kayano D, Kinuya S.　Semin Nucl Med　2023/01/12
  • 　Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan　Akatani N, Wakabayashi H, Kayano D, Inaki A, Takata A, Hiromasa T, Yamase T, Kunita Y, Watanabe S, Mori H, Saito S, Nakajima K, Kinuya S.　Endocr J　2022/12/24
  • 　Prognostic value of olfactory nerve damage measured with thallium-based olfactory imaging in patients with idiopathic olfactory dysfunction　Hideki Shiga, Junichi Taki, Okuda Koichi, Naoto Watanabe, Hisao Tonami, HIdeaki Nakagawa, Seigo Kinuya, Takaki Miwa　Scientific Repoarts　7　3581　2017/06/15
  • 　Validation of Left Ventricular Ejection Fraction with the IQ•SPECT System in Small-Heart Patients.　Yoneyama H, Shibutani T, Konishi T, Mizutani A, Hashimoto R, Onoguchi M, Okuda K, Matsuo S, Nakajima K, Kinuya S.　J Nucl Med Technol.　45　3　201-207　2017
  • 　Phase II study of radium‑223 dichloride in Japanese patients with symptomatic castration‑resistant prostate cancer　Nobuaki Matsubara, Satsohi Nagamori, Yoshiaki Wakumoto, Hirotsugu Uemura, Go Kimura, Akira Yokomizo,Hiroaki Kikukawa, Atsushi Mizokami, Takeo Kosaka, Naoya Masumori,Yoshihide Kawasaki, Junji Yonese,Yasutomo Nasu,Satoshi Fukasawa,Takayuki Sugiyama, Seigo Kinuya,Makoto Hosono,Iku Yamaguchi,Hirokazu Tsutsui,Hiroji Uemura　Int J Clin Oncol　2017
  • 　Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.　Watanabe S, Nakajima K, Mizokami A, Yaegashi H, Noguchi N, Kawashiri S, Inokuchi M, Kinuya S.　Ann Nucl Med　31　3　201-210　2017
  • 　Current status of radioactive iodine therapy for thyroid cancer　SEIGO KINUYA　89　11　900-908　2017
  • 　Complete remission of metastatic pheochromocytoma in 123I-metaiodobenzylguanidine scintigraphy after a single session of 131I-metaiodobenzylguanidine therapy: a case report.　Sugino T, Ando R, Unno R, Iida K, Naiki T, Hamamoto S, Mizuno K, Okada A, Umemoto Y, Kawai N, Tozawa K, Hayashi Y, Inaki A, Kayano D, Kinuya S, Yasui T.　BMC Res Notes　2017/12/19
  • 　Quantification of Myocardial Perfusion Defect Size in Rats: Comparison between Quantitative Perfusion SPECT and Autoradiography.　Wakabayashi H, Taki J, Inaki A, Hiromasa T, Okuda K, Shibutani T, Shiba K, Kinuya S.　Mol Imaging Biol　2018/01/16
  • 　Consideration for radioiodine therapy　90　5　314-315　2018
  • 　Feasibility of High-dose Iodine-131-metaiodobenzylguanidine Therapy for High-risk Neuroblastoma Preceding Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation: a Study Protocol　 Raita Araki; Ryosei Nishimura; Anri Inaki; Hiroshi Wakabayashi; Yasuhito Imai; Yoshikazu Kuribayashi; Kenichi Yoshimura; Toshinori Murayama; Seigo Kinuya 　Asia Oceania Journal of Nuclear Medcine and Biology　6　2　161-166　2018
  • 　Three year follow up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases　Hirotsugu Uemura, Hiroji Uemura, Satsohi Nagamori, Yoshiaki Wakumoto, Go Kimura, Hiroaki Kikukawa, Akira Yokomizo, Atsushi Mizokami, Takeo Kosaka, Naoya Masumori, Yoshihide Kawasaki, Junji Yonese, Yasutomo Nasu, Satoshi Fukasawa, Takayuki Sugiyama, Seigo Kinuya, Makoto Hosono, Iku Yamaguchi, Takashi Akagawa, Nobuaki Matsubara　International Journal of Clinical Oncology　2019
  • 　Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases　Shunji Takahashi . Seigo Kinuya . Norio Nonomura . Nobuo Shinohara . Kazuhiro Suzuki . Hiroyoshi Suzuki . Katsumasa Nakamura . Takefumi Satoh . Ukihide Tateishi . Toshiyuki Yoneda . Hiroyuki Horikoshi . Tsukasa Igawa . Takao Kamai . Mitsuru Koizumi . Takeo Kosaka . Nobuaki Matsubara . Hideaki Miyake . Atsushi Mizokami . Takashi Mizowaki . Naoki Nakamura . Masahiro Nozawa . Takeo Takahashi . Hiroji Uemura . Motohide Uemura . Akira Yokomizo . Mana Yoshimura . Yoshiyuki Kakehi　Oncol Ther　6　2　157–171　2018
  • 　Imaging modalities for drug-related osteonecrosis of the jaw (5), utility of bone scintigraphy and 18F-FDG PET/CT in early detection and risk assessment of medication-related osteonecrosis of the jaw (secondary publication)　Satoru Watanabe, Kenichi Nakajima, Seigo Kinuya　Japanese Dental Science Review　55　1　76-79　2019/03/29
  • 　Activities for the Development of Targeted Radionuclide Therapy in Japan.　Nucl Med Mol Imaging.　1　53　35-37　2019
  • 　Postconditioning Accelerates Myocardial Inflammatory Resolution Demonstrated by 14C-Methionine Imaging and Attenuates Ventricular Remodeling After Ischemia and Reperfusion.　Taki J, Inaki A, Wakabayashi H, Matsunari I, Imanaka-Yoshida K, Ogawa K, Hiroe M, Shiba K, Kinuya S.　Circ J. 　83　12　2520-2526　2019/11/25
  • 　Impact of iterative reconstruction with resolution recovery in myocardial perfusion SPECT: phantom and clinical studies.　Okuda K, Nakajima K, Yoneyama H, Shibutani T, Onoguchi M, Matsuo S, Hashimoto M, Kinuya S.　Sci Rep　23　1　19618　2019/12
  • 　High-dose 131I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in Japan　Kayano D, Wakabayashi H, Nakajima K, Kuroda R, Watanabe S, Inaki A, Toratani A, Akatani N, Yamase T, Kunita Y, Hiromasa T, Takata A, Mori H, Saito S, Araki R, Taki J, Kinuya S.　2020/03/26
  • 　Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic Cholangiocarcinomas　Kazuto Kozaka , Satoshi Kobayashi , Hiroyuki Takamura, Yasunori Sato , Azusa Kitao , Dai Inoue , Norihide Yoneda, Hidehiro Tajima , Seigo Kinuya , Kenichi Harada, Tetsuo Ohta, Wataru Koda, Osamu Matsui, Toshifumi Gabata 　Clin Nucl Med　45　6　e267-e273　2020/06/01
  • 　Diagnostic Use of Post-therapy 131I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma　Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Raita Araki, Rie Kuroda, Norihito Akatani, Takafumi Yamase, Satoru Watanabe, Tomo Hiromasa, Yuji Kunita, Hiroshi Mori, Shintaro Saito, Yasuhiro Ikawa, Toshihiro Fujiki and Seigo Kinuya　Diagnostics　10　663　2020/09/02
  • 　High-dose 131 I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience　Wakabayashi H, Kayano D, Inaki A, Araki R, Kuroda R, Ikawa Y, Fujiki T, Akatani N, Yamase T, Watanabe S, Hiromasa T, Kunita Y, Mori H, Saito S, Nishimura R, Wada T, Kinuya S.　Ann Nucl Med　2020/08/29
  • 　Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents 　Uemura H, Masumori N, Takahashi S, Hosono M, Kinuya S, Sunaya T, Horio T, Okayama Y, Kakehi Y.　Int J Clin Oncol.　26　4　753-763　2021/02/11
  • 　68Ga- and 211At-Labeled RGD Peptides for Radiotheranostics with Multiradionuclides　Kazuma Ogawa, Hiroaki Echigo, Kenji Mishiro, Saki Hirata, Kohshin Washiyama, Yoji Kitamura, Kazuhiro Takahashi, Kazuhiro Shiba, and Seigo Kinuya　Molecular Pharmaceutical　18　9　3553-3562　2021/08/18
  • 　Development and evaluation of a theranostic probe with RGD peptide introduced platinum complex to enable tumor-specific accumulation　Echigo H, Mishiro K, Munekane M, Fuchigami T, Kitamura Y, Kinuya S, Ogawa K.　Bioorg Med Chem　70　116919　2022/07/05
  • 　RGD Peptide-Conjugated Dodecaborate with the Ga−DOTA Complex: A Preliminary Study for the Development of Theranostic Agents for Boron Neutron Capture Therapy and Its Companion Diagnostics　Kenji Mishiro, Sayaka Imai, Yuki Ematsu, Katsumi Hirose, Takeshi Fuchigami, Masayuki Munekane,Seigo Kinuya, and Kazuma Ogawa　J Med Chem　65　24　16741-16753.　2022/12/22
  • 　Synthesis and evaluation of radiolabeled porphyrin derivatives for cancer diagnoses and their nonradioactive counterparts for photodynamic therapy　Ramzi NI, Mishiro K, Munekane M, Fuchigami T, Hu X, Jastrząb R, Kitamura Y, Kinuya S, Ogawa K.　13　12　1565-1574　2022/09/22
  • 　Methods of calculating 123I-β-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy　Chen Z, Nakajima K, Hirano KI, Kamiya T, Yoshida S, Saito S, Kinuya S.　Ann Nucl Med　36　11　986-997　2022/11/01
  • 　Safety and response after peptide receptor radionuclide therapy with 177 Lu-DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trial.　Kudo A, Tateishi U, Yoshimura R, Tsuchiya J, Yokoyama K, Takano S, Kobayashi N, Utsunomiya D, Hata M, Ichikawa Y, Tanabe M, Hosono M, Kinuya S.　J Hepatobiliary Pancreat Sci　29　4　487-499　2022/04/01
  • 　Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation.　Kuroda R, Wakabayashi H, Araki R, Inaki A, Nishimura R, Ikawa Y, Yoshimura K, Murayama T, Imai Y, Funasaka T, Wada T, Kinuya S.　Eur J Nucl Med Mol Imaging　49　5　1574-1583　2022/04/01
  • 　Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan　Akatani N, Wakabayashi H, Kayano D, Inaki A, Takata A, Hiromasa T, Yamase T, Kunita Y, Watanabe S, Mori H, Saito S, Nakajima K, Kinuya S.　Endocr J　2022/12/24
  • 　Prognostic factors for refractory pheochromocytoma and paraganglioma after 131I-metaiodobenzylguanidine therapy 　Hiromasa T, Wakabayashi H, Kayano D, Inaki A, Watanabe S, Mori H, Akatani N, Yamase T, Kunita Y, Saito S, Kinuya S.　Ann Nucl Med　36　1　61-69　2022/01/01
  • 　Diagnosis of Parkinson syndrome and Lewy-body disease using 123 I-ioflupane images and a model with image features based on machine learning　Nakajima K, Saito S, Chen Z, Komatsu J, Maruyama K, Shirasaki N, Watanabe S, Inaki A, Ono K, Kinuya S.　Ann Nucl Med　36　8　765-776　2022/07/07
  • 　Feasibility of 125I-RGD uptake as a marker of angiogenesis after myocardial infarction　Yamase T, Taki J, Wakabayashi H, Inaki A, Hiromasa T, Mori H, Akatani N, Ogawa K, Shiba K, Kinuya S.　Ann Nucl Med　36　3　235-243　2022/03/01
  • 　Development of Radiohalogenated Osimertinib Derivatives as Imaging Probes for Companion Diagnostics of Osimertinib. 　Mishiro K, Nishii R, Sawazaki I, Sofuku T, Fuchigami T, Sudo H, Effendi N, Makino A, Kiyono Y, Shiba K, Taki J, Kinuya S, Ogawa K.　J Med Chem.　65　3　1835-1847　2022/01/11
  • 　Artificial neural network retrained to detect myocardial ischemia using a Japanese multicenter database.　Nakajima K, Okuda K, Watanabe S, Matsuo S, Kinuya S, Toth K, Edenbrandt L.　Ann Nucl Med　32　5　303-310　2018
  • 　Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer.　Mori H, Nakajima K, Kadomoto S, Mizokami A, Ikeda H, Wakabayashi H, Kinuya S.　Intern Med　2018
  • 　Objective evaluation of cerebrovascular reactivity for acetazolamide predicts cerebral hyperperfusion after carotid artery stenting: Comparison with region of interest methods.　Misaki K, Uchiyama N, Inaki A, Kinuya S, Nambu I, Kamide T, Mohri M, Hayashi Y, Nakada M.　J Neuroradiol　S0150-9861　17　30361-9　2018
  • 　The Imaging and Dosimetry for Targeted Ra-223 Treatment for Metastatic Castration-Resistant Prostate Cancer.　Matsuo S, Mizokami A, Wakabayashi H, Nakajima K, Kudo T and Kinuya S.　Austin J Nucl Med Radiother　5　1　1024　2018
  • 　Objective evaluation of cerebrovascular reactivity for acetazolamide predicts cerebral hyperperfusion after carotid artery stenting: Comparison with region of interest methods.　Misaki K, Uchiyama N, Inaki A, Kinuya S, Nambu I, Kamide T, Mohri M, Hayashi Y, Nakada M.　J Neuroradiol. 　S0150-9861　17　30361-9　2018
  • 　Is 123I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal database　Kenichi Nakajima, Koichi Okuda, Shinro Matsuo, Hiroshi Wakabayashi, Seigo Kinuya　Ann Nucl Med　32　2018/01/15
  • 　Update of diagnostic imaging for prostate cancer　1　2　75-81　2018
  • 　Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.).　Hosono M, Ikebuchi H, Nakamura Y, Nakamura N, Yamada T, Yanagida S, Kitaoka A, Kojima K, Sugano H, Kinuya S, Inoue T, Hatazawa J.　Ann Nucl Med　2018/01/15
  • 　Comparison of Radioiodine- or Radiobromine-Labeled RGD Peptides between Direct and Indirect Labeling Methods.　Ogawa K, Takeda T, Yokokawa M, Yu J, Makino A, Kiyono Y, Shiba K, Kinuya S, Odani A.　Chem Pharm Bull (Tokyo)　66　6　651-659　2018
  • 　Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer.　Mori H, Nakajima K, Kadomoto S, Mizokami A, Ikeda H, Wakabayashi H, Kinuya S.　Intern Med. 2018 Jun 6. 　2018
  • 　Activities for the development of targeted radionuclide therapy in Japan　Seigo Kinuya　Nuclear Medeicine and Molecular Imaging　2019
  • 　Radiotheranostics Coupled between an At-211-Labeled RGD Peptide and the Corresponding Radioiodine-Labeled RGD Peptide　Kazuma Ogawa, Takuya Takeda, Kenji Mishiro, Atsushi ToyoshiKazuma Ogawa*†‡ , Takuya Takeda‡, Kenji Mishiro† , Atsushi Toyoshima§, Kazuhiro Shiba∥, Takashi Yoshimuma, Kazuhiro Shiba, Takashi Yoshimura , Atsushi Shinohara, Seigo Kinuya, and Akira Odani　ACS Omega　2019
  • 　131I-MIBG therapy with WT-1 peptide for refractory neuroblastoma　Minako Sugiyama Kinuya Seigo Yosuke Hosoya Akihiro Iguchi Atsushi Manabe　Pediatrics International　2020/06/01
  • 　Current Consensus on I-131 MIBG Therapy　Kayano D, Kinuya S　Nuclear Medicine and Molecular Imaging　52　1-12　2018
  • 　Synthesis and Fundamental Evaluation of Radioiodinated Rociletinib (CO-1686) as a Probe to Lung Cancer with L858R/T790M Mutations of Epidermal Growth Factor Receptor (EGFR)　Muammar Fawwaz, Kenji Mishiro, Ryuichi Nishii, Izumi Sawazaki, Kazuhiro Shiba, Seigo Kinuya and Kazuma Ogawa　Molecules　25　12　2914　2020/06/24
  • 　Decreasing undesirable absorbed radiation to the intestine after administration of radium-223 dichloride for treatment of bone metastases　Kazuma Ogawa, Takuma Higashi, Kenji Mishiro, Hiroshi Wakabayashi, Kazuhiro Shiba, Akira Odani & Seigo Kinuya 　Scientific Report　10　11917 　2020/07/17
  • 　Pharmacological intervention with angiotensin II and kininase inhibitor enhanced efficacy of radioimmunotherapy in human colon cancer xenografts.　JOURNAL OF NUCLEAR MEDICINE　41　7　1244-1249　2000/07
  • 　Anti-angiogenic therapy and radioimmunotherapy in colon cancer xenografts　EUROPEAN JOURNAL OF NUCLEAR MEDICINE　28　9　1306-1312　2001/09
  • 　New section in EJNMMI and Annals of Nuclear Medicine.　Carrió I, Kinuya S.　Ann Nucl Med. 　30　9　593　2016
  • 　Enhanced efficacy of radioimmunotherapy combined with systemic chemotherapy and local hyperthermia in xenograft model　JAPANESE JOURNAL OF CANCER RESEARCH　91　5　573-578　2000/05
  • 　Assessment of left ventricular systolic and diastolic function based on the edge detection method with myocardial ECG-gated SPET　EUROPEAN JOURNAL OF NUCLEAR MEDICINE　28　10　1512-1516　2001/10
  • 　Esophageal hypomotility in systemic sclerosis: close relationship with pulmonary involvement　ANNALS OF NUCLEAR MEDICINE　15　2　97-101　2001/04
  • 　A nuclear power plant accident in Fukushima: What should we do?　Kinuya, Seigo　Annals of Nuclear Medicine　26　2　113-114　2012/02/01　
  • 　Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.　Okuda K, Nakajima K, Matsuo S, Kondo C, Sarai M, Horiguchi Y, Konishi T, Onoguchi M, Shimizu T, Kinuya S.　Ann Nucl Med　2017
  • 　Creation and characterization of normal myocardial perfusion imaging databases using the IQ·SPECT system.　Okuda K, Nakajima K, Matsuo S, Kondo C, Sarai M, Horiguchi Y, Konishi T, Onoguchi M, Shimizu T, Kinuya S.　J Nucl Cardiol　10.1007/s12350-016-0770-2　2017
  • 　99mTc-tetrofosmin uptake in bone metastases from breast cancer　ANNALS OF NUCLEAR MEDICINE　12　5　293-296　1998/10
  • 　177Lu-EDTMP: A potential therapeutic bone agent　NUCLEAR MEDICINE COMMUNICATIONS　19　6　587-591　1998/06
  • 　Development of a myocardial phantom and analysis system toward the standardization of myocardial SPECT image across institutions.　Shibutani T, Onoguchi M, Katafuchi T, Kinuya S.　Ann Nucl Med　30　10　699-707　2016/12/01
  • 　Clinical approach to renal study incidental to 99mTc-MDP bone scintigraphy　ANNALS OF NUCLEAR MEDICINE　15　3　237-245　2001/06
  • 　Early detection of x-ray CT negative recurrent lung cancer with Tl-201 SPECT　CLINICAL NUCLEAR MEDICINE　22　3　196-197　1997/03
  • 　Differential uptake of Tl-201 by small-cell lung cancer in a patient with pneumoconiosis-related pulmonary nodules　CLINICAL NUCLEAR MEDICINE　24　9　687-690　1999/09
  • 　Combination radioimmunotherapy with local hyperthermia: increased delivery of radioimmunoconjugate by vascular effect and its retention by increased antigen expression in colon cancer xenografts　CANCER LETTERS　140　1-2　209-218　1999/01
  • 　Experimental investigation of I-123 iodoamphetamine in the detection of lung cancer　LUNG CANCER　25　1　1-6　1999/01
  • 　Increased uptake of 99mTc-HL91 in tumor cells exposed to X-ray radiation　ANNALS OF NUCLEAR MEDICINE　14　2　139-141　2000/02
  • 　Forward cardiac output measurement with first-pass technique using 99mTc-labeled myocardial perfusion imaging agents　JOURNAL OF NUCLEAR MEDICINE　40　11　1874-1881　1999/11
  • 　Improved response of colon cancer xenografts to radioimmunotherapy with pentoxifylline treatment　EUROPEAN JOURNAL OF NUCLEAR MEDICINE　28　6　750-755　2001/06
  • 　Efficacy, toxicity and mode of interaction of combination radioimmunotherapy with 5-fluorouracil in colon cancer xenografts　JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY　125　11　630-636　1999/11
  • 　Incidential detection of pulmonary infection during the evaluation of protein losing enteropathy with In-111 transferrin.　CLINICAL NUCLEAR MEDICINE　22　6　297-398　1997/06
  • 　Mallory-Weiss syndrome caused by radiation sickness of I-131 therapy for metastatic thyroid carcinoma　JOURNAL OF NUCLEAR MEDICINE　38　11　1831　1997/11
  • 　Methylxanthine sensitization of human colon cancer cells to 186Re-monoclonalantibody　JOURNAL OF NUCLEAR MEDICINE　42　4　596-600　2001/04
  • 　Optimal timing of administration of hyperthermia in combined radioimmunotherapy　Cancer Biotherapy and Radiopharmceuticals　15　4　373-379　2000/04
  • 　Preparation and in vivo characteristics of 99mTc-EDTMP - comparison with 99mTc-MDP　Memoirs Health Scl Med Kanazawa Univ　23　2　989-995　1999/12
  • 　Experimental radioimmunotherapy with 186Re-MAG3-A7 anti-colorectal cancer monoclonal antibody: comparison with 131I-counterpart　ANNALS OF NUCLEAR MEDICINE　15　3　199-202　2001/06
  • 　Production of 105Rh-EDTMP and its bone accumulation　APPLIED RADIATION AND ISOTOPES　52　2　211-215　2000/02
  • 　Reversible cerebral hypoperfusion observed with Tc-99m HMPAO SPECT in reversible dementia caused by hypothyroidism　CLINICAL NUCLEAR MEDICINE　24　9　666-668　1999/06
  • 　Radiotoxicity after strontium-89 therapy for bone metastases using the micronucleus assay　JOURNAL OF NUCLEAR MEDICINE　39　12　2077-2079　1998/12
  • 　Relationship between hemodynamic parapeters during exercise and cardiac function　Memoirs Health Scl Med Kanazawa University　21　37-44　1997/10
  • 　Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay　JOURNAL OF NUCLEAR MEDICINE　39　3　436-4　1998/10
  • 　Multiple myeloma evaluated with 201Tl scintigraphy compared with bone scintigraphy　JOURNAL OF NUCLEAR MEDICINE　40　7　1138-1142　1999/07
  • 　Preoperative assessment of residual hepatic function reserve using 99mTc-DTPA-galactosyl-human albumin dynamic SPECT　JOURNAL OF NUCLEAR MEDICINE　40　10　1644-1651　1999/10
  • 　Systemic-portal shunt in unilateral iliac vein stenosis.　CLINICAL NUCLEAR MEDICINE　22　6　404-406　1997/06
  • 　Survey of myeloblastoma with Ga-67 scan in a patient with acute leukemia　CLINICAL NUCLEAR MEDICINE　22　6　434-437　1997/06
  • 　Prevalence of deep vein thrombosis in the lower limbs and the pelvis and pulmonary embolism in patients with positive antiphospholipid antibodies　ANNALS OF NUCLEAR MEDICINE　15　6　495-497　2001/12
  • 　Changes of 99mTc-sestamibi uptake in P-glycoprotein expressing leukemia cells treated in vivo with antisense oligodeoxynucleotide complementary to mdr-1 mRNA　Bai J, Yokoyama K, Shiba K, Mori H, Fukuoka M, Watanabe N, Shuke N, Michigishi T, Tonami N　World Journal of Nuclear Medicine　5　2　115-118　2006/04
  • 　99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells　Bai J, Shiba K, Yokoyama K, Mori H, Fukuoka M, Watanabe M, Shuke N, Michigishi T, Tonami N　ANNALS OF NUCLEAR MEDICINE　20　1　29-34　2006/01
  • 　Intraperitoneal radioimmunotherapy to treat early phase of peritoneal dissemination of human colon cancer cells in a murine model　NUCLEAR MEDICINE COMMUNICATIONS　28　2007
  • 　Scintigraphic detection of varicoceles in infertile men　Memoirs Health Scl Med Kanazawa Univ　22　29-34　1998/10
  • 　In Vivo Differences between Two Optical Isomers of Radioiodinated o-iodo-trans-decalinvesamicol for Use as a Radioligand for the Vesicular Acetylcholine Transporter.　Uno I, Kozaka T, Miwa D, Kitamura Y, Azim MA, Ogawa K, Taki J, Kinuya S, Shiba K.　PLoS One.　11　1　e0146719　2016
  • 　Effects of the belt electrode skeletal muscle electrical stimulation system on lower extremity skeletal muscle activity: Evaluation using positron emission tomography.　Numata H, Nakase J, Inaki A, Mochizuki T, Oshima T, Takata Y, Kinuya S, Tsuchiya H.　J Orthop Sci　21　1　53-56　2016
  • 　A case of double cancers with myocardial metastasis mimicking acute myocardial infarction both on an electrocardiogram and on Tc-99m-MIBI myocardial SPECT　ANNALS OF NUCLEAR MEDICINE　15　4　381-385　2001/08
  • 　Early response of tumour to radiotherapy should be assessed by both uptake and retention of single photon tracers: In vitro analysis with 201Tl chloride, 99Tcm-sestamibi and 99Tcm-tetrofosmin in human bladder cancer cells and human leucocytes　NUCLEAR MEDICINE COMMUNICATIONS　20　6　581-588　1999/06
  • 　Assessment of olfactory nerve by SPECT-MRI image with nasal thallium-201 administration in patients with olfactory impairments in comparison to healthy volunteers.　Shiga H,Taki J,Washiyama K,Yamamoto J,Kinase S,Okuda K,Kinuya S,Watanabe N,Tonami H,Koshida K,Amano R,Furukawa M,Miwa T　PLoS One　8　2　e57671　2013
  • 　Changes in muscle activity after performing the FIFA 11+ programme part 2 for 4 weeks.　Takata Y, Nakase J, Inaki A, Mochizuki T, Numata H, Oshima T, Kinuya S, Tsuchiya H.　J Sports Sci　34　20　2011-2017　2016
  • 　Reducing the small-heart effect in pediatric gated myocardial perfusion single-photon emission computed tomography.　Yoneyama H, Nakajima K, Okuda K, Matsuo S, Onoguchi M, Kinuya S, Edenbrandt L.　J Nucl Cardiol　2016
  • 　Optimization of the filter parameters in (99m)Tc myocardial perfusion SPECT studies: the formulation of flowchart.　Shibutani T, Onoguchi M, Yamada T, Kamida H, Kunishita K, Hayashi Y, Nakajima T, Kinuya S.　Australas Phys Eng Sci Med　39　2　571-581　2016
  • 　Innovative exercise device for the abdominal trunk muscles: An early validation study.　Kato S, Murakami H, Inaki A, Mochizuki T, Demura S, Nakase J, Yoshioka K, Yokogawa N, Igarashi T, Takahashi N, Yonezawa N, Kinuya S, Tsuchiya H.　PLoS One.　12　2　e0172934　2017
  • 　Molecular Imaging for Personalized Medicine.　Russell J, Tian J, Kinuya S, Shen B, Li XF.　Biomed Res Int.　5170159　2016
  • 　Evaluation of cytological radiation damage to lymphocytes after I-131 metaiodobenzylguanidine therapy by the cytokinesis-blocked micronucleus assay.　Watanabe N, Yokoyama K, Kinuya S, Tonami H.　Ann Nucl Med.　30　9　624-628　2016
  • 　Short-period-induced hypertension could improve tumor-to-nontumor ratios of radiolabeled monoclonal antibody　NUCLEAR MEDICINE AND BIOLOGY　24　6　547-551　1997/06
  • 　Technetium-99m-Tetrofosmin Would Be a Substrate for Multidrug Resistance-associated Protein (MRP): Comparison between a Leukemia Cell Line with High MRP Gene Expression and Its Parental Cell Line　Cancer Biotherapy and Radiopharmceuticals　16　1　17-24　2001/02
  • 　Evaluation of the olfactory nerve transport function by SPECT-MRI fusion image with nasal thallium-201 administration.　Shiga H,Taki J,Yamada M,Washiyama K,Amano R,Matsuura Y,Matsui O,Tatsutomi S,Yagi S,Tsuchida A,Yoshizaki T,Furukawa M,Kinuya S,Miwa T　Mol Imaging Biol　13　6　1262-6　2011
  • 　Comparison of phase dyssynchrony analysis using gated myocardial perfusion imaging with four software programs: Based on the Japanese Society of Nuclear Medicine working group normal database.　Nakajima K, Okuda K, Matsuo S, Kiso K, Kinuya S, Garcia EV.　J Nucl Cardiol.　2016
  • 　Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology.　Shibata H, Kato S, Sekine I, Abe K, Araki N, Iguchi H, Izumi T, Inaba Y, Osaka I, Kato S, Kawai A, Kinuya S, Kodaira M, Kobayashi E, Kobayashi T, Sato J, Shinohara N, Takahashi S, Takamatsu Y, Takayama K, Takayama K, Tateishi U, Nagakura H, Hosaka M, Morioka H, Moriya T, Yuasa T, Yurikusa T, Yomiya K, Yoshida M.　ESMO Open　１　２　e000037　2016
  • 　Thallium-201 scintigraphy for the assessment of long-term prognosis in patients with osteosarcoma.　Inaki A,Taki J,Wakabayashi H,Sumiya H,Zen Y,Tsuchiya H,Kinuya S　Ann Nucl Med　26　7　545-50　2012
  • 　Whole Body Muscle Activity during the FIFA 11+ Program Evaluated by Positron Emission Tomography.　Nakase J,Inaki A,Mochizuki T,Toratani T,Kosaka M,Ohashi Y,Taki J,Yahata T,Kinuya S,Tsuchiya H　PLoS One　8　9　e73898　2013
  • 　Adrenal mass and renal vessels mimicking intestinal bleeding in Tc-99m red blood cell scintigraphy　CLINICAL NUCLEAR MEDICINE　22　11　785-786　1997/11
  • 　Persistent distension and enhanced diffusive extravasation of tumor vessels improved uniform tumor targeting of radioimmunoconjugate in mice administered with angiotensin II and kininase inhibitor　ONCOLOGY RESEARCH　10　11-12　551-559　1998/11
  • 　Rhenium-186-mercaptoacetyltriglycine Labeled Monoclonal Antibody for Radioimmunotherapy: In vitro Assessment, in vivo Kinetics and Dosimetry in Tumor-bearing Nude Mice　JAPANESE JOURNAL OF CANCER RESEARCH　89　8　870-878　1998/08
  • 　Radionuclide cisternography in intracranical hypotension syndrome　ANNALS OF NUCLEAR MEDICINE　16　1　75　2002/01
  • 　Functional mapping of regional liver asialoglycoprotein receptor amount from single blood sample and SPECT　JOURNAL OF NUCLEAR MEDICINE　44　3　475-482　2003/03
  • 　Hypoxia as a factor for Ga-67 accumulation in tumor cells　NUCLEAR MEDICINE COMMUNICATIONS　25　1　49-53　2004/01
  • 　 Limitations of 99mTc-tetrofosmin in assessing reversal effects of verapamil on multi-drug resistance associated protein 1 (MRP1) function.　NUCLEAR MEDICINE COMMUNICATIONS　25　7　585-589　2004/07
  • 　Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice　EUROPEAN JOURNAL OF NUCLEAR MEDICINE　29　8　1006　2002/08
  • 　Role of brain perfusion single-photon emission tomography in traumatic head injury　NUCLEAR MEDICINE COMMUNICATIONS　25　4　333-337　2004/04
  • 　Intense 201Tl uptake in giant-cell tumour of bone　NUCLEAR MEDICINE COMMUNICATIONS　23　8　595　2002/08
  • 　Preliminary evaluation of image reconstruction by ordered-subset expectation maximiZation in thallium-201 lung scintigraphy　ANNALS OF NUCLEAR MEDICINE　17　7　619-624　2003/10
  • 　Locoregional radioimmunotherapy with 186Re-labeled monoclonal antibody in treating small peritoneal carcinomatosis of colon cancer in mice in comparison with 131I-counterpart　CANCER LETTERS　219　1　41-48　2005/01
  • 　227Th-EDTMP: a potential therapeutic agent for bone metastasis　NUCLEAR MEDICINE AND BIOLOGY　31　9　901-908　2004/09
  • 　Brown adipose tissue: evaluation with 201Tl and 99mTc-sestamibi dual-tracer SPECT　ANNALS OF NUCLEAR MEDICINE　18　6　547-549　2004/12
  • 　Cooperative effect of radioimmunotherapy and antiangiogenic therapy with thalidomide in human cancer xenografts　JOURNAL OF NUCLEAR MEDICINE　43　8　1084　2002/08
  • 　Thallium-201 SPECT with triple-headed gamma camera for differential diagnosis of small plumonary nodular lesion 20 mm in diameter of smaller　ANNALS OF NUCLEAR MEDICINE　14　2　91-95　2000/04
  • 　Statistical parametric mapping in brain single photon computed emission tomography after carbon monoxide intoxication　NUCLEAR MEDICINE COMMUNICATIONS　23　4　355　2002/04
  • 　Radioimmunotherapy with 186Re-labeled monoclonal antibody to treat liver metastases of colon cancer cells in nude mice　CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS　17　6　681　2002/12
  • 　A new method for measuring dynamic change of tracer distribution using dynamic single photon emission tomography with a slip-ring rotational gamma camera　NUCLEAR MEDICINE COMMUNICATIONS　23　11　1115　2002/11
  • 　Benefits of combined radioimmunotherapy and anti-angiogenic therapy in a liver metastasis model of human colon cancer cells　EUROPEAN JOURNAL OF NUCLEAR MEDICINE　29　12　1669　2002/12
  • 　Anti-angiogenic therapy and radioimmuhnotherapy in colon cancer xenografts　EUROPEAN JOURNAL OF NUCLEAR MEDICINE　28　9　1306　2001/09
  • 　Differentiation of soft tissue hemangioma by 201Tl scintigraphy　NUCLEAR MEDICINE COMMUNICATIONS　24　2　327-330　2003/02
  • 　Intraperitoneal radioimmunotherapy in treating peritoneal carcinomatosis of colon cancer in mice compared with systemic radioimmunotherapy　JAPANESE JOURNAL OF CANCER RESEARCH　94　7　650-654　2003/07
  • 　Estimation of fractional liver uptake and blood retention of 99mTc-DTPA-galactosyl human serum albumin　NUCLEAR MEDICINE COMMUNICATIONS　24　4　503-511　2003/04
  • 　Evaluation of left and right ventricular functional parameters with automatic edge detection program of ECG gated blood SPET　NUCLEAR MEDICINE COMMUNICATIONS　24　4　559-563　2003/04
  • 　Visualization of bone structure with Tc-99m MIBI in a patient on hemodyalysis.　CLINICAL NUCLEAR MEDICINE　22　5　331-332　1997/05
  • 　Improved survival of mice bearing liver metastases of colon cancer cells treated with combination of radioimmunotherapy and antiangiogenic therapy　EUROPEAN JOURNAL OF NUCLEAR MEDICINE　31　7　981-985　2004/07
  • 　Thymic lesions in patients with myasthenia gravis: characterization with thallium 201 schintigraphy　RADIOLOGY　221　1　201-206　2001/10
  • 　Prognostic value of Tc-99m-MIBI performed during middle course of preoperative chemotherapy in patients with malignant bone and soft-tissue tumors.　Wakabayashi H,Taki J,Inaki A,Sumiya H,Zen Y,Tsuchiya H,Kinuya S　Clin Nucl Med　37　1　1-8
  • 　Improvement of the (99m)Tc-ECD brain uptake ratio (BUR) method for measurement of cerebral blood flow.　Ito S,Takaki A,Inoue S,Tomiguchi S,Shiraishi S,Akiyama Y,Sasaki T,Odajima S,Teraoka S,Hosoya T,Soma T,Miyazaki Y,Kinuya S,Yamashita Y　Ann Nucl Med　26　4　351-8
  • 　Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy.　Kusakabe K,Yokoyama K,Ito K,Shibuya H,Kinuya S,Ito M,Higashi T,Togawa T,Koizumi K,Yoshimura M,Uchiyama M,Okamoto T,Kanaya S,Kanaya K,Yoneyama T,Ikebuchi H,Yanagida S,Shibata K,Segawa K,Yamamoto A　Ann Nucl Med　26　4　370-8
  • 　Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study.　Nakajima K,Okuda K,Matsuo S,Yoshita M,Taki J,Yamada M,Kinuya S　Eur J Nucl Med Mol Imaging　39　1　113-9
  • 　Assessment of doxorubicin cardiac toxicity using gated ⁹⁹mTc-hexakis-2-methoxyisobutylisonitrile myocardial single photon emission computed tomography: wall thickening and motion abnormalities can be an early sign of cardiac involvement.　Wakabayashi H,Taki J,Inaki A,Sumiya H,Tsuchiya H,Kinuya S　Circ J　76　5　1190-6
  • 　Radioactive iodine (131I) therapy for differentiated thyroid cancer in Japan: current issues with historical review and future perspective.　Higashi T,Kudo T,Kinuya S　Ann Nucl Med　26　2　99-112
  • 　A nuclear power plant accident in Fukushima: what should we do?　Ann Nucl Med　26　2　113-4
  • 　Thallium-201 scintigraphy for the assessment of long-term prognosis in patients with osteosarcoma.　Inaki A,Taki J,Wakabayashi H,Sumiya H,Zen Y,Tsuchiya H,Kinuya S　Ann Nucl Med　26　7　545-50
  • 　I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma.　Sato Y,Kurosawa H,Fukushima K,Okuya M,Hagisawa S,Sugita K,Arisaka O,Inaki A,Wakabayashi H,Nakamura A,Fukuoka M,Kayano D,Kinuya S　Ital J Pediatr　38　53
  • 　Optimization of iterative reconstruction parameters with attenuation correction, scatter correction and resolution recovery in myocardial perfusion SPECT/CT.　Okuda K,Nakajima K,Yamada M,Wakabayashi H,Ichikawa H,Arai H,Matsuo S,Taki J,Hashimoto M,Kinuya S　Ann Nucl Med
  • 　Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.　Wakabayashi H,Nakajima K,Mizokami A,Namiki M,Inaki A,Taki J,Kinuya S　Ann Nucl Med　27　9　802-7
  • 　[Targeted radionuclide therapy - where should we go ?].　Gan To Kagaku Ryoho　40　2　133-8
  • 　Sensitive immunodetection of radiotoxicity after iodine-131 therapy for thyroid cancer using γ-H2AX foci of DNA damage in lymphocytes.　Doai M,Watanabe N,Takahashi T,Taniguchi M,Tonami H,Iwabuchi K,Kayano D,Fukuoka M,Kinuya S　Ann Nucl Med　27　3　233-8
  • 　Improved Detection of Sentinel Lymph Nodes in SPECT/CT Images Acquired Using a Low- to Medium-Energy General-Purpose Collimator.　Yoneyama H,Tsushima H,Kobayashi M,Onoguchi M,Nakajima K,Kinuya S　Clin Nucl Med
  • 　Prototype imaging protocols for monitoring the efficacy of iodine-131 ablation in differentiated thyroid cancer.　Kobayashi M,Wakabayashi H,Kojima H,Konishi T,Okuda K,Yoneyama H,Kayano D,Tobisaka M,Tsushima H,Onoguchi M,Kawai K,Kinuya S　Hell J Nucl Med　16　3　175-80
  • 　Improved quantification of small hearts for gated myocardial perfusion imaging.　Nakajima K,Okuda K,Nyström K,Richter J,Minarik D,Wakabayashi H,Matsuo S,Kinuya S,Edenbrandt L　Eur J Nucl Med Mol Imaging　40　8　1163-70
  • 　Prognostic values of initial responses to low-dose (131)I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma.　Wakabayashi H,Taki J,Inaki A,Nakamura A,Kayano D,Fukuoka M,Matsuo S,Nakajima K,Kinuya S　Ann Nucl Med　27　9　839-46
  • 　14C-Methionine uptake as a potential marker of inflammatory processes after myocardial ischemia and reperfusion.　Taki J,Wakabayashi H,Inaki A,Imanaka-Yoshida K,Hiroe M,Ogawa K,Morooka M,Kubota K,Shiba K,Yoshida T,Kinuya S　J Nucl Med　54　3　431-6
  • 　Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging.　Okuda K,Nakajima K,Hosoya T,Ishikawa T,Konishi T,Matsubara K,Matsuo S,Kinuya S　J Nucl Cardiol　18　1　82-9
  • 　Esophageal transit study using a sliding sum image: application to patients with probable and definite systemic sclerosis.　Nakajima K,Hasegawa M,Inaki A,Wakabayashi H,Hosoya T,Takehara K,Kinuya S　Ann Nucl Med　25　5　325-31
  • 　Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.　Fukuoka M,Taki J,Mochizuki T,Kinuya S　Clin Nucl Med　36　1　1-7
  • 　Quantification of myocardial perfusion SPECT using freeware package (cardioBull).　Okuda K,Nakajima K,Hosoya T,Ishikawa T,Matsuo S,Kawano M,Taki J,Kinuya S　Ann Nucl Med　25　8　571-9
  • 　Low-dose (123)I-metaiodobenzylguanidine diagnostic scan is inferior to (131)I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma.　Kayano D,Taki J,Fukuoka M,Wakabayashi H,Inaki A,Nakamura A,Kinuya S　Nucl Med Commun　32　10　941-6
  • 　Cause of apical thinning on attenuation-corrected myocardial perfusion SPECT.　Okuda K,Nakajima K,Matsuo S,Wakabayashi H,Taki J,Kinuya S　Nucl Med Commun　32　11　1033-9
  • 　Tc-99m human serum albumin lymphoscintigraphy with SPECT/CT in chylothorax.　Kayano D,Taki J,Wakabayashi H,Kinuya S　Clin Nucl Med　36　11　1056-7
  • 　Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification.　Wakabayashi H,Nakajima K,Fukuoka M,Inaki A,Nakamura A,Kayano D,Kinuya S　Ann Nucl Med　25　9　609-15
  • 　The relationship between stress-induced myocardial ischemia and coronary artery atherosclerosis measured by hybrid SPECT/CT camera.　Matsuo S,Nakajima K,Okuda K,Kinuya S　Ann Nucl Med　25　9　650-6
  • 　Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study.　Nakajima K,Okuda K,Matsuo S,Yoshita M,Taki J,Yamada M,Kinuya S　Eur J Nucl Med Mol Imaging　39　1　113-9
  • 　Sensitive immunodetection of radiotoxicity after iodine-131 therapy for thyroid cancer using γ-H2AX foci of DNA damage in lymphocytes.　Doai M,Watanabe N,Takahashi T,Taniguchi M,Tonami H,Iwabuchi K,Kayano D,Fukuoka M,Kinuya S　Ann Nucl Med　27　3　233-8
  • 　A nuclear power plant accident in Fukushima: what should we do?　Ann Nucl Med　26　2　113-4
  • 　I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma.　Sato Y,Kurosawa H,Fukushima K,Okuya M,Hagisawa S,Sugita K,Arisaka O,Inaki A,Wakabayashi H,Nakamura A,Fukuoka M,Kayano D,Kinuya S　Int J Med Sci　38　53
  • 　Improved quantification of small hearts for gated myocardial perfusion imaging.　Nakajima K,Okuda K,Nyström K,Richter J,Minarik D,Wakabayashi H,Matsuo S,Kinuya S,Edenbrandt L　Eur J Nucl Med Mol Imaging　40　8　1163-70
  • 　Assessment of doxorubicin cardiac toxicity using gated ⁹⁹mTc-hexakis-2-methoxyisobutylisonitrile myocardial single photon emission computed tomography: wall thickening and motion abnormalities can be an early sign of cardiac involvement.　Wakabayashi H,Taki J,Inaki A,Sumiya H,Tsuchiya H,Kinuya S　Circ J　76　5　1190-6
  • 　Prognostic value of Tc-99m-MIBI performed during middle course of preoperative chemotherapy in patients with malignant bone and soft-tissue tumors.　Wakabayashi H,Taki J,Inaki A,Sumiya H,Zen Y,Tsuchiya H,Kinuya S　Clin Nucl Med　37　1　1-8
  • 　Improved Detection of Sentinel Lymph Nodes in SPECT/CT Images Acquired Using a Low- to Medium-Energy General-Purpose Collimator.　Yoneyama H,Tsushima H,Kobayashi M,Onoguchi M,Nakajima K,Kinuya S　Clin Nucl Med
  • 　Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy.　Kusakabe K,Yokoyama K,Ito K,Shibuya H,Kinuya S,Ito M,Higashi T,Togawa T,Koizumi K,Yoshimura M,Uchiyama M,Okamoto T,Kanaya S,Kanaya K,Yoneyama T,Ikebuchi H,Yanagida S,Shibata K,Segawa K,Yamamoto A　Ann Nucl Med　26　4　370-8
  • 　Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma.　Wakabayashi H,Taki J,Inaki A,Nakamura A,Kayano D,Fukuoka M,Matsuo S,Nakajima K,Kinuya S　Ann Nucl Med
  • 　Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.　Wakabayashi H,Nakajima K,Mizokami A,Namiki M,Inaki A,Taki J,Kinuya S　Ann Nucl Med
  • 　[Targeted radionuclide therapy - where should we go ?].　Gan To Kagaku Ryoho　40　2　133-8
  • 　14C-Methionine uptake as a potential marker of inflammatory processes after myocardial ischemia and reperfusion.　Taki J,Wakabayashi H,Inaki A,Imanaka-Yoshida K,Hiroe M,Ogawa K,Morooka M,Kubota K,Shiba K,Yoshida T,Kinuya S　J Nucl Med　54　3　431-6
  • 　Time course of discordant BMIPP and thallium uptake after ischemia and reperfusion in a rat model.　Higuchi T,Taki J,Nakajima K,Kinuya S,Namura M,Tonami N　J Nucl Med　46　1　172-5
  • 　Anti-angiogenic therapy and chemotherapy affect 99mTc sestamibi and 99mTc-HL91 accumulation differently in tumour xenografts.　Kinuya S,Yokoyama K,Fukuoka M,Mori H,Shiba K,Watanabe N,Shuke N,Michigishi T,Tonami N　Nucl Med Commun　26　12　1067-73
  • 　Characterization of cartilaginous tumors with 201Tl scintigraphy.　Higuchi T,Taki J,Sumiya H,Kinuya S,Nakajima K,Namura M,Tonami N　Ann Nucl Med　19　2　95-9
  • 　Sonographically guided core biopsy of the salivary gland masses: safety and efficacy.　Taki S,Yamamoto T,Kawai A,Terahata S,Kinuya K,Tonami H　Clin Imaging　29　3　189-94
  • 　Locoreginal radioimmunotherapy with 186Re-labeled monoclonal antibody in treating small peritoneal carcinomatosis of colon cancer in mice in comparison with 131I-counterpart.　Kinuya S,Yokoyama K,Izumo M,Sorita T,Obata T,Mori H,Shiba K,Watanabe N,Shuke N,Michigishi T,Tonami N　Cancer Lett　219　1　41-8
  • 　Tc-99m MAA SPECT in pectus excavatum: assessment of perfusion volume changes after correction by the Nuss procedure.　Kinuya K,Ueno T,Kobayashi T,Tuji T,Yamamoto Y,Kinuya S　Clin Nucl Med　30　12　779-82
  • 　A simple and rapid radiochemical choline acetyltransferase (ChAT) assay screening test.　Shiba K,Ogawa K,Kinuya S,Yajima K,Mori H　J Neurosci Methods　157　1　98-102
  • 　Binding with serum components favorably affects cellular uptake of 111In-oligonucleotide in a leukemia cell line.　Bai J,Kinuya S,Shiba K,Michigishi T,Tonami N　Cancer Biother Radiopharm　21　1　34-40
  • 　99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells.　Kinuya S,Bai J,Shiba K,Yokoyama K,Mori H,Fukuoka M,Watanabe N,Shuke N,Michigishi T,Tonami N　Ann Nucl Med　20　1　29-34
  • 　Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model.　Yoshimoto M,Kinuya S,Kawashima A,Nishii R,Yokoyama K,Kawai K　Nucl Med Biol　33　8　963-9
  • 　Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer.　Kinuya S,Yokoyama K,Michigishi T,Tonami N　Ann Nucl Med　20　7　499-502
  • 　Changes in the levels of CD4+ and CD8+ T-lymphocytes after strontium-89 chloride therapy for painful bone metastases in patients correlate with treatment efficacy.　Li Y,Li XF,Ma Y,Fang N,Russell J,Ma D,Sun X,Han X,Yang H,Kinuya S　Cancer Biother Radiopharm　22　3　367-73
  • 　Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio.　Nakajima K,Matsubara K,Ishikawa T,Motomura N,Maeda R,Akhter N,Okuda K,Taki J,Kinuya S　J Nucl Cardiol　14　6　843-51
  • 　In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent.　Akhter N,Shiba K,Ogawa K,Kinuya S,Nakajima K,Mori H　Nucl Med Biol　34　6　697-702
  • 　Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment.　Taki J,Higuchi T,Kawashima A,Fukuoka M,Kayano D,Tait JF,Matsunari I,Nakajima K,Kinuya S,Strauss HW　J Nucl Med　48　8　1301-7
  • 　Intraperitoneal radioimmunotherapy to treat the early phase of peritoneal dissemination of human colon cancer cells in a murine model.　Kinuya S,Yokoyama K,Fukuoka M,Hiramatsu T,Mori H,Shiba K,Watanabe N,Shuke N,Michigishi T,Tonami N　Nucl Med Commun　28　2　129-33
  • 　Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model.　Ogawa K,Mukai T,Asano D,Kawashima H,Kinuya S,Shiba K,Hashimoto K,Mori H,Saji H　J Nucl Med　48　1　122-7
  • 　Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model.　Ogawa K,Mukai T,Asano D,Kawashima H,Kinuya S,Shiba K,Hashimoto K,Mori H,Saji H　J Nucl Med　48　1　122-7
  • 　Intraperitoneal radioimmunotherapy to treat the early phase of peritoneal dissemination of human colon cancer cells in a murine model.　Kinuya S,Yokoyama K,Fukuoka M,Hiramatsu T,Mori H,Shiba K,Watanabe N,Shuke N,Michigishi T,Tonami N　Nucl Med Commun　28　2　129-33
  • 　In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent.　Akhter N,Shiba K,Ogawa K,Kinuya S,Nakajima K,Mori H　Nucl Med Biol　34　6　697-702
  • 　Changes in the levels of CD4+ and CD8+ T-lymphocytes after strontium-89 chloride therapy for painful bone metastases in patients correlate with treatment efficacy.　Li Y,Li XF,Ma Y,Fang N,Russell J,Ma D,Sun X,Han X,Yang H,Kinuya S　Cancer Biother Radiopharm　22　3　367-73
  • 　Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio.　Nakajima K,Matsubara K,Ishikawa T,Motomura N,Maeda R,Akhter N,Okuda K,Taki J,Kinuya S　J Nucl Cardiol　14　6　843-51
  • 　Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment.　Taki J,Higuchi T,Kawashima A,Fukuoka M,Kayano D,Tait JF,Matsunari I,Nakajima K,Kinuya S,Strauss HW　J Nucl Med　48　8　1301-7
  • 　Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model.　Ogawa K,Mukai T,Asano D,Kawashima H,Kinuya S,Shiba K,Hashimoto K,Mori H,Saji H　J Nucl Med　48　1　122-7
  • 　Intraperitoneal radioimmunotherapy to treat the early phase of peritoneal dissemination of human colon cancer cells in a murine model.　Kinuya S,Yokoyama K,Fukuoka M,Hiramatsu T,Mori H,Shiba K,Watanabe N,Shuke N,Michigishi T,Tonami N　Nucl Med Commun　28　2　129-33
  • 　In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent.　Akhter N,Shiba K,Ogawa K,Kinuya S,Nakajima K,Mori H　Nucl Med Biol　34　6　697-702
  • 　Changes in the levels of CD4+ and CD8+ T-lymphocytes after strontium-89 chloride therapy for painful bone metastases in patients correlate with treatment efficacy.　Li Y,Li XF,Ma Y,Fang N,Russell J,Ma D,Sun X,Han X,Yang H,Kinuya S　Cancer Biother Radiopharm　22　3　367-73
  • 　Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment.　Taki J,Higuchi T,Kawashima A,Fukuoka M,Kayano D,Tait JF,Matsunari I,Nakajima K,Kinuya S,Strauss HW　J Nucl Med　48　8　1301-7
  • 　Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio.　Nakajima K,Matsubara K,Ishikawa T,Motomura N,Maeda R,Akhter N,Okuda K,Taki J,Kinuya S　J Nucl Cardiol　14　6　843-51
  • 　Regional wall thickening in gated myocardial perfusion SPECT in a Japanese population: effect of sex, radiotracer, rotation angles and frame rates.　Akhter N,Nakajima K,Okuda K,Matsuo S,Yoneyama T,Taki J,Kinuya S　Eur J Nucl Med Mol Imaging　35　9　1608-15
  • 　The sentinel node concept in prostate cancer: Present reality and future prospects.　Egawa M,Fukuda M,Takashima H,Misaki T,Kinuya K,Terahata S　Indian J Urol　24　4　451-6
  • 　Cardiac scintigraphic findings of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: A case report.　Matsuo S,Nakajima K,Kinuya S,Sato Y,Matsumoto N,Horie M　Exp Clin Cardiol　13　2　93-5
  • 　Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders.　Nakajima K,Yoshita M,Matsuo S,Taki J,Kinuya S　Q J Nucl Med Mol Imaging　52　4　378-87
  • 　Localization of metastases from malignant pheochromocytoma in patients undergoing 131I-MIBG therapy with manually fused 123I-MIBG SPECT and CT images.　Kizu H,Takayama T,Tsushima H,Noguchi A,Nakajima K,Onoguchi M,Kinuya S　J Nucl Med Technol　36　4　186-8
  • 　Potential usefulness of D2R reporter gene imaging by IBF as gene therapy monitoring for cerebellar neurodegenerative diseases.　Shiba K,Torashima T,Hirai H,Ogawa K,Akhter N,Nakajima K,Kinuya S,Mori H　J Cereb Blood Flow Metab　29　2　434-40
  • 　[Assessment for the image interpretation of 111In-ibritumomab tiuxetan in the phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma].　Oriuchi N,Koizumi K,Koizumi M,Terui S,Yamaura H,Imai Y,Kaneta T,Nawano S,Kubo A,Nishimura T,Kinuya S,Tobinai K,Endo K　Kaku Igaku　45　2　99-113
  • 　Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations.　Matsuo S,Nakajima K,Okuda K,Kawano M,Ishikawa T,Hosoya T,Taki J,Kinuya S　Eur J Nucl Med Mol Imaging　36　4　560-6
  • 　[Guideline draft of appropriate use of 131I-MIBG for internal radiotherapy of neuroendocrine tumors].　Nakajo M,Yoshinaga K,Oriuchi N,Kinuya S,Yokoyama K,Yamaguchi T,Drafting Committee for Guideline of Internal Radiotherapy with 131I-MIBG,Japanese Society of Nuclear Medicine in Oncology and Immunology,Japanese Society of Nuclear Medicine　Kaku Igaku　45　1　suppl 1-40
  • 　A change of in vivo characteristics depending on specific activity of radioiodinated (+)-2-[4-(4-iodophenyl)piperidino]cyclohexanol [(+)-pIV] as a ligand for sigma receptor imaging.　Akhter N,Shiba K,Ogawa K,Tsuji S,Kinuya S,Nakajima K,Mori H　Nucl Med Biol　35　1　29-34
  • 　[Recent topics in targeted radiotherapy: metastron, zevalin and thyroid cancer].　Nihon Hoshasen Gijutsu Gakkai Zasshi　65　5　659-67
  • 　Preparation and evaluation of 186/188Re-labeled antibody (A7) for radioimmunotherapy with rhenium(I) tricarbonyl core as a chelate site.　Ogawa K,Kawashima H,Kinuya S,Shiba K,Onoguchi M,Kimura H,Hashimoto K,Odani A,Saji H　Ann Nucl Med　23　10　843-8
  • 　Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations.　Matsuo S,Nakajima K,Okuda K,Kawano M,Ishikawa T,Hosoya T,Taki J,Kinuya S　Eur J Nucl Med Mol Imaging　36　4　560-6
  • 　Potential usefulness of D2R reporter gene imaging by IBF as gene therapy monitoring for cerebellar neurodegenerative diseases.　Shiba K,Torashima T,Hirai H,Ogawa K,Akhter N,Nakajima K,Kinuya S,Mori H　J Cereb Blood Flow Metab　29　2　434-40
  • 　The importance of population-specific normal database for quantification of myocardial ischemia: comparison between Japanese 360 and 180-degree databases and a US database.　Nakajima K,Okuda K,Kawano M,Matsuo S,Slomka P,Germano G,Kinuya S　J Nucl Cardiol　16　3　422-30
  • 　Gated myocardial perfusion SPECT for preoperative risk stratification in patients with noncardiac vascular disease.　Kayano D,Nakajima K,Ohtake H,Kinuya S　Ann Nucl Med　23　2　173-81
  • 　Nuclear medicine practice in Japan: a report of the sixth nationwide survey in 2007.　Kuwabara Y,Koizumi K,Ushijima Y,Kinuya S,Kinomura S,Suga K,Takeoka H,Takeda T,Toyama H,Arao Y,Nishiyama Y,Murakami K,Morita K　Ann Nucl Med　23　2　209-15
  • 　Attenuation correction of myocardial SPECT by scatter-photopeak window method in normal subjects.　Okuda K,Nakajima K,Motomura N,Kubota M,Yamaki N,Maeda H,Matsuo S,Kinuya S　Ann Nucl Med　23　5　501-6
  • 　Clinical usefulness of novel cardiac MDCT/SPECT fusion image.　Matsuo S,Nakajima K,Akhter N,Wakabayashi H,Taki J,Okuda K,Kinuya S　Ann Nucl Med　23　6　579-86
  • 　Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy.　Ogawa K,Shiba K,Akhter N,Yoshimoto M,Washiyama K,Kinuya S,Kawai K,Mori H　Cancer Sci　100　11　2188-92
  • 　Esophageal transit scintigraphy and structured questionnaire in patients with systemic sclerosis with endoscopically proven reflux esophagitis.　Nakajima K,Inaki A,Hiramatsu T,Hasegawa M,Fujimoto M,Takehara K,Kinuya S　Ann Nucl Med　23　9　771-6
  • 　[The role of / 18FDG PET/CT for the initial staging and therapy in primary breast cancer].　Inokuchi M,Furukawa H,Kayahara M,Ohta T,Kawashima H,Taki J,Kinuya S　Gan To Kagaku Ryoho　36　13　2526-31
  • 　Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice.　Yagi Y,Fushida S,Harada S,Tsukada T,Kinoshita J,Oyama K,Fujita H,Ninomiya I,Fujimura T,Kayahara M,Kinuya S,Yashiro M,Hirakawa K,Ohta T　Cancer Chemother Pharmacol　66　4　745-53
  • 　Evaluation of the Olfactory Nerve Transport Function by SPECT-MRI Fusion Image with Nasal Thallium-201 Administration.　Shiga H,Taki J,Yamada M,Washiyama K,Amano R,Matsuura Y,Matsui O,Tatsutomi S,Yagi S,Tsuchida A,Yoshizaki T,Furukawa M,Kinuya S,Miwa T　Mol Imaging Biol
  • 　Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice.　Yagi Y,Fushida S,Harada S,Tsukada T,Kinoshita J,Oyama K,Fujita H,Ninomiya I,Fujimura T,Kayahara M,Kinuya S,Yashiro M,Hirakawa K,Ohta T　Cancer Chemother Pharmacol　66　4　745-53
  • 　Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification.　Wakabayashi H,Nakajima K,Fukuoka M,Inaki A,Nakamura A,Kayano D,Kinuya S　Ann Nucl Med
  • 　Quantification of myocardial perfusion SPECT using freeware package (cardioBull).　Okuda K,Nakajima K,Hosoya T,Ishikawa T,Matsuo S,Kawano M,Taki J,Kinuya S　Ann Nucl Med
  • 　Esophageal transit study using a sliding sum image: application to patients with probable and definite systemic sclerosis.　Nakajima K,Hasegawa M,Inaki A,Wakabayashi H,Hosoya T,Takehara K,Kinuya S　Ann Nucl Med　25　5　325-31
  • 　Clinical use of nuclear cardiology in the assessment of heart failure.　Matsuo S,Nakajima K,Kinuya S　World J Cardiol　2　10　344-56
  • 　Early prediction of histopathological tumor response to preoperative chemotherapy by Tc-99m MIBI imaging in bone and soft tissue sarcomas.　Taki J,Inaki A,Wakabayashi H,Sumiya H,Tsuchiya H,Zen Y,Kinuya S　Clin Nucl Med　35　3　154-9
  • 　Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.　Fukuoka M,Taki J,Mochizuki T,Kinuya S　Clin Nucl Med　36　1　1-7
  • 　Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging.　Okuda K,Nakajima K,Hosoya T,Ishikawa T,Konishi T,Matsubara K,Matsuo S,Kinuya S　J Nucl Cardiol　18　1　82-9
  • 　Identification of myocardial damage in systemic sclerosis: a nuclear cardiology approach.　Nakajima K,Matsuo S,Hasegawa M,Kinuya S,Takehara K　Int J Rheumatol　2010
  • 　123I-metaiodobenzylguanidine imaging in the era of implantable cardioverter defibrillators: beyond ejection fraction.　Matsunari I,Taki J,Nakajima K,Kinuya S　J Nucl Med　51　8　1171-3
  • 　Dynamic expression of tenascin-C after myocardial ischemia and reperfusion: assessment by 125I-anti-tenascin-C antibody imaging.　Taki J,Inaki A,Wakabayashi H,Imanaka-Yoshida K,Ogawa K,Hiroe M,Shiba K,Yoshida T,Kinuya S　J Nucl Med　51　7　1116-22
  • 　Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction.　Matsunari I,Aoki H,Nomura Y,Takeda N,Chen WP,Taki J,Nakajima K,Nekolla SG,Kinuya S,Kajinami K　Circ Cardiovasc Imaging　3　5　595-603
  • 　I-131 uptake in a thymic cyst.　Kayano D,Michigishi T,Ichiyanagi K,Inaki A,Kinuya S　Clin Nucl Med　35　6　438-9
  • 　Cause of apical thinning on attenuation-corrected myocardial perfusion SPECT.　Okuda K,Nakajima K,Matsuo S,Wakabayashi H,Taki J,Kinuya S　Nucl Med Commun
  • 　Low-dose 123I-metaiodobenzylguanidine diagnostic scan is inferior to 131I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma.　Kayano D,Taki J,Fukuoka M,Wakabayashi H,Inaki A,Nakamura A,Kinuya S　Nucl Med Commun　32　10　941-6
  • 　The relationship between stress-induced myocardial ischemia and coronary artery atherosclerosis measured by hybrid SPECT/CT camera.　Matsuo S,Nakajima K,Okuda K,Kinuya S　Ann Nucl Med

Conference Presentations

  • Bringing lutetium-PSMA earlier in prostate cancer(2024/02/01)
  • 核医学治療をご存じですか？(conference：第23回日本内分泌学会九州支部学術大会)(2023/09/02)
  • Development of new bone-seeking radiolabeled compounds(conference：Congress of European Association of Nuclear Medicine 2023)(2023/09/09)
  • Building a Normative Database for [18F]-FDG imaging: Insights from a Japanese Screening Cohort(conference：Congress of European Association of Nuclear Medicine 2023)(2023/09/09)
  • Comparison of Standardized Uptake Values of [18F]FDG- PET/CT imaging of healthy volunteers: a multi-country PET/CT study(conference：Congress of European Association of Nuclear Medicine 2023)(2023/09/09)

show all

  • Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia(conference：Congress of European Association of Nuclear Medicine 2023)(2023/09/09)
  • Positive Protective Effects of Sigma-1 Receptor Stimulation with Fluvoxamine after Myocardial Ischemia and Reperfusion in Rat(conference：Congress of European Association of Nuclear Medicine 2023)(2023/09/09)
  • Dynamic Expression of Myocardial Sigma-1 Receptor in Doxorubicin-Induced Cardiomyopathy using Radioiodine Labeled 2-[4-(2iodophenyl)piperidino]cyclopentanol (OI5V) Imaging(conference：Congress of European Association of Nuclear Medicine 2023)(2023/09/09)
  • Automated absolute quantitation of cardiac sympathetic activity using convolutional neural network and 123I-MIBG SPECT/CT(conference：Congress of European Association of Nuclear Medicine 2023)(2023/09/09)
  • Flare phenomenon of 99mTc-bone scintigraphy is a determinant of prognosis in patients with metastatic castration-resistant prostate cancer(conference：Congress of European Association of Nuclear Medicine 2023)(2023/09/09)
  • Variational autoencoder for detecting coronary artery disease in myocardial perfusion SPECT(conference：Congress of European Association of Nuclear Medicine 2023)(2023/09/09)
  • Image characteristics of 99mTc myocardial perfusion SPECT/CT using a new multi-focal collimator: comparison with conventional SPECT with LEHR collimator(conference：Congress of European Association of Nuclear Medicine 2023)(2023/09/09)
  • A machine-learning-based prediction model of lethal arrhythmic events by using the123I-meta- iodobenzylguanidine derived late heart-to-mediastinum ratio: Application into separate Japanese and European cohorts(conference：Congress of European Association of Nuclear Medicine 2023)(2023/09/09)
  • Current situation of RIA examination in Japan(conference：RIA summit in Asia)(2022/05/12)
  • Recent progress of theranostics in Japan (conference：Development of Nuclear Medicine Healthcare and Health Industry Summit in China)(2022/08/05)
  • Recent progress of theranostics in Japan(conference：International Symposium on Honor of the Retirement of Professor Jae Min Jeong)(2021/08/12)
  • Theranostics and future perspective in NET (2021/01/23)
  • 転移DTCに対するRAI治療ー予後不良因子に基づくRAI抵抗性判断の再考(2020/09/29)
  • 転移DTCに対するRAI治療ー予後不良因子に基づくRAI抵抗性判断の再考(2020/07/30)
  • 転移DTCに対するRAI治療ー予後不良因子に基づくRAI抵抗性判断の再考(2020/06/26)
  • Single photon製剤に将来はあるのか？(2020/09/10)
  • 予後不良因子に基づくRAI抵抗性判断の再考(2020/11/26)
  • I-131内用療法の現状と将来展望 (2020/07/17)
  • 放射能でがんを治す - 核医学治療をご存じですか？(2020/02/08)
  • Future direction of precision nuclear medicine(conference：2019 Annual Congress of Korean Society of Nuclear Medicine)(2019/10/25)
  • Theranosticsの現状と展望(2019/09/07)
  • Theranostics in Japan(conference：International Conference on Radiopharmaceutical Therapy 2019)(2019/08/22)
  • Precision Nuclear Medicine(2019/08/30)
  • α線内用療法の有効性（臨床応用に関する基礎的事項）(conference：塩化ラジウム（Ra223)注射液を用いたRI内用療法における適正使用に関する安全取扱講習会)(2019/07/20)
  • Theranostics in Japan (conference：Asia Oceania Congress of Nuclear Medicine and Biology)(2019/05/11)
  • Nuclear theranostics in the world and what is required for the Japanese community (2019/04/12)
  • Theranostics in Japan(conference：5th Theranostics World Congress)(2019/03/01)
  • Precision Nuclear Medicine(2019/01/12)
  • The latest achievement in nuclear medicine(conference：Modern treatment options for thyroid cancer)(2018/09/24)
  • Radioiodine (RAI) therapy in thyroid cancer - its role and timing to switch to TKI (conference：1st Congress of Russian Society for Radiation Oncology)(2018/09/25)
  • 放射免疫療法(radioimmunotherapy)の意義と将来 (conference：RIT Conference 2018)(2018/07/01)
  • Benefit/Risk estimation and radiological protection in special groups (conference：12th Congress of the World Federation of Nuclear Medicine and Biology)(2018/04/23)
  • Treatment of hyperthyroidism Japanese experience (conference：12th Congress of the World Federation of Nuclear Medicine and Biology)(2018/04/23)
  • Scientific writing: Authorship and ethics (conference：12th Congress of the World Federation of Nuclear Medicine and Biology)(2018/04/23)
  • Increasing demand of targeted radionuclide therapy(conference：RI Science Evolution 2018 (RISE18))(2018/03/16)
  • α線内用療法の有効性（臨床応用に関する基礎的事項）(conference：塩化ラジウム（Ra223)注射液を用いたRI内用療法における適正使用に関する安全取扱講習会)(2018/01/13)
  • Future application of theranostics(conference：IAEA/RCA regional training course on theragnostics and dementias)(2017/12/08)
  • Technetium-99m radiopharmaceuticals for other cancer diagnosis (Including related area) (conference：IAEA Technical Cooperation Expert Mission)(2017/11/22)
  • Radiopharmaceuticals for cancer therapy (conference：IAEA Technical Cooperation Expert Mission)(2017/11/22)
  • Utilization of radionuclides in nuclear medicine. Nuclear medicine practice in Japan: a report of the 7th nationwide survey in 2012 + tentative on-going data of the 8th survey in 2017 (conference：Seminar Nasional Pendyagunaan Teknologi Nuklir (SENPATEN))(2017/11/21)
  • Technetium-99m radiopharmaceuticals for bone scan (conference：IAEA Technical Cooperation Expert Mission)(2017/11/22)
  • 放射性医薬品による診断と治療の融合 Radionuclide Theranostics(2017/09/09)
  • 放射性ヨウ素治療の現状から、今後の甲状腺癌治療を考える(2017/10/13)
  • 症例からの治療アプローチ(2017/10/12)
  • How to write scientific papers - authorship and ethics(conference：12th Asia Oceania Congress of Nuclear Medicine and Biology)(2017/10/07)
  • International Symposium Strategies for the future of nuclear medicine(conference：12th Asia Oceania Congress of Nuclear Medicine and Biology)(2017/10/07)
  • Targeted radionuclide therapyの意義　Zevalinを例に(2017/09/25)
  • 放射性ヨウ素治療の現状から今後の甲状腺癌治療を考える (conference：甲状腺セミナーin兵庫)(2017/09/23)
  • 臨床応用(conference： I-131（1,110MBq)による残存甲状腺破壊（アブレーション）の外来治療における適正使用に関する講習会)(2017/09/02)
  • 放射性ヨウ素治療の今後の方向性 (2017/09/02)
  • 腫瘍核医学における最新トピックス (2017/08/31)
  • 放射性ヨウ素治療の現状から今後の甲状腺癌治療を考える (conference：京都放射性ヨウ素治療研究会)(2017/07/21)
  • α線内用療法の有効性（臨床応用に関する基礎的事項）(conference：塩化ラジウム（Ra223)注射液を用いたRI内用療法における適正使用に関する安全取扱講習会)(2017/07/22)
  • RAI(radioactive iodine)不応性を克服できないか？(2017/07/15)
  • Effects of Fukushima Daiichi Nuclear Disaster (conference：Korean Medical Association)(2017/07/01)
  • Radioiodine therapy for thyroid cancer - things we have to think about for the future (conference：Daegyeong Chapter of the Korean Society of Nuclear Medicine)(2017/06/30)
  • Radioiodine therapy and imaging guided strategy(conference：24th Asia Pacific Cancer Conference)(2017/06/23)
  • Radionuclide theranostics(2017/06/20)
  • 放射性ヨウ素治療の現状から今後の甲状腺癌治療を考える(2017/06/17)
  • Radionuclide theranostics(2017/06/20)
  • 内用療法一緒にやってみる？(2017/05/27)
  • Concept of targeted radionuclide therapy For the future of interdisciplinary collaboration (conference：Translational Immunology - from target to therapy IV)(2017/05/05)
  • Targeted radionuclide therapy with 131I-MIBG for malignant neuroendcrine tumors: experience for 14 years(conference：World　Association of Radiopharmaceutical and Molecular Therapy)(2015/10/31)
  • 基礎と安全管理　放射性同位元素の取扱(2017/04/22)
  • RI内用療法（本邦における最近のトピック）(2017/04/23)
  • 分子標的薬の開始基準を考える From 核医学的 point of view (2017/03/31)
  • Recent advance in targeted radionuclide therapy: toward individualized evidence based medicine(conference：15th International Congress of Radiation Reseach)(2015/05/26)
  • Present status and strategy to develop targeted radionuclide therapy in Japan(conference：Asia Regional Cooperative Council of Nuclear Medicine)(2016/07/15)
  • Recent basic researches on targeted radionuclide therapy in Japan(conference：11th International Conference on Radiopharmaceuticlas)(2016/11/14)
  • Establishment of National Congress of Targeted Radionuclide Therapy(conference：17th Chinese Symposium on Nuclear Cardiology)(2016/07/01)
  • Tharanostic use of "オクトレオスキャン”(conference：NET Progress Japan)(2017/02/25)
  • Way to develop targeted radionuclide therapy in Japan(conference：The 3rd International Symposium on Targeted Radionuclide Therapy)(2017/02/12)
  • Radionuclide theranostics(2017/06/20)

Others

  • 　Optimization of radioimmunotherapy interactions with hyperthermia　20　2　190-200　2004/03
  • 　99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells.　2006
  • 　Binding with serum components favorably affects cellular uptake of 111In-oligonucleotide in a leukemia cell line.　2006
  • 　Changes of 99mTc-sestamibi uptake in P-glycoprotein expressing leukemia cells treated in vivo with antisense oligodeoxynucleotide complementary to mdr-1 mRNA.　2006
  • 　Respiratory distress caused by radioiodine therapy in aptients with differentiated thyroid cancer.　2006

show all

  • 　Eradication of colon cancer cells before tumour formation in the peritoneal cavity of mice treated with intraperitoneal Re-186 radioimmunotherapy.　2006
  • 　Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model.　2006
  • 　simple and rapid radiochemical choline acetyltransferase (ChAT) assay screening test.　2006
  • 　herapeutic effects for the palliation of metastatic bone pain of a rhenium-186 complex-conjugated bisphosphonate in an animal model.　2007
  • 　Changes in the levels of CD4+ and CD8+ T-lymphocytes after strontium-89 chloride therapy for painful bone metastases in patients correlate with treatment efficacy.　2007
  • 　Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio.　2007
  • 　Effect of postconditioning on myocardial 99mTc-Annexin-V uptake: comparison with Ischemic preconditioning and caspase Inhibitor treatment.　2007

Arts and Fieldwork

Patent

Theme to the desired joint research

Grant-in-Aid for Scientific Research

○「高リスク化学療法不応性神経芽腫に対する新治療戦略の開発」(2021-2021)　
○「高リスク化学療法不応性神経芽腫に対する新治療戦略の開発」(2020-2021)　
○「高リスク化学療法不応性神経芽腫に対する新治療戦略の開発」(2019-2021)　
○「進行消化器癌に対するα線核種内照射療法による治療戦略の確立」(2018-2018)　
○「進行消化器癌に対するα線核種内照射療法による治療戦略の確立」(2016-2018)　
○「悪性神経内分泌腫瘍に対する131I-MIBG内照射療法の開発」(2015-2017)　
○「悪性神経内分泌腫瘍に対する分子生物学的・組織学的特徴に基づいた集学的内照射療法」(2010-2011)　
○「悪性神経内分泌腫瘍に対する血管新生阻害下内用療法：基礎研究から臨床応用へ」(2007-2009)　
○「癌細胞膜アビジン発現とスカベンジャー受容体内在化による特異的普遍的内照射療法の開発」(2004-2006)　
○「放射性化合物内照射療法と血管新生阻害療法との同調効果による癌転移巣の制御」(2002-2003)　
○「DNA修復阻害・腫瘍内酸素化改善による放射性医薬品内照射療法の抗腫瘍効果増強」(2000-2001)　
○「腫瘍血行動態改善による放射能標識モノクローナル抗体の治療効果増強に関する研究」(1997-1998)　
○「原発性アルドステロン症における新治療戦略ー安全かつ高奏功な根本治療の開発」(2022-2025)　
○「細胞内レドックス制御を司るがん幹細胞治療の標的トランスポーター画像診断薬の開発」(2022-2025)　
○「放射線療法の提供体制構築に資する研究」(2021-2022)　
○「高リスク化学療法不応性神経芽腫に対する新治療戦略の開発」(2019-2021)　
○「高リスク化学療法不応性神経芽腫に対する新治療戦略の開発」(2019-2021)　

Competitive research funding,Contribution

Collaborative research,Consignment study

Classes (Bachelors)

○Nuclean Medicine(BSL)(2017)
○Nuclean Medicine(BSL)(2016)

Classes (Graduate Schools)

○Introduction to Medical Science(2021)
○Exploring and preventive diagnostics(2021)
○Biotracer Medicine(2021)
○Biotracer Medicine(2021)
○Exploring and preventive diagnostics(2017)
○Biotracer Medicine(2017)
○Biotracer Medicine(2017)
○Biotracer Medicine(2017)
○Biotracer Medicine(2016)
○Biotracer Medicine(2016)
○Exploring and preventive diagnostics(2016)
○Biotracer Medicine(2016)

International Project

○IAEA workshopIAEA, 日本外務省(20191205-20191208)program organizer
○IAEA Scientific visitIAEA(20191125-20191128)program organizer
○Workshop on Paediatric Nuclear Medicine (including Paediatric Oncology)(20190221-20210331)Organizer on Workshop on Paediatric Nuclear Medicine (including Paediatric Oncology)
○Supporting IAEA technical cooperative programmes for human resources development in radiation medicine(2018-2021)

International Students

Lecture themes

Others (Social Activities)

To Page Top